{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T06:32:04Z","timestamp":1789713124379,"version":"4.0.1"},"reference-count":461,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2024,7,16]],"date-time":"2024-07-16T00:00:00Z","timestamp":1721088000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,7,16]]},"abstract":"<jats:p>Amyloid protein-\u03b2 (A\u03b2) concentrations are increased in the brain in both early onset and late onset Alzheimer\u2019s disease (AD). In early onset AD, cerebral A\u03b2 production is increased and its clearance is decreased, while increased A\u03b2 burden in late onset AD is due to impaired clearance. A\u03b2 has been the focus of AD therapeutics since development of the amyloid hypothesis, but efforts to slow AD progression by lowering brain A\u03b2 failed until phase 3 trials with the monoclonal antibodies lecanemab and donanemab. In addition to promoting phagocytic clearance of A\u03b2, antibodies lower cerebral A\u03b2 by efflux of A\u03b2-antibody complexes across the capillary endothelia, dissolving A\u03b2 aggregates, and a \u201cperipheral sink\u201d mechanism. Although the blood-brain barrier is the main route by which soluble A\u03b2 leaves the brain (facilitated by low-density lipoprotein receptor-related protein-1 and ATP-binding cassette sub-family B member 1), A\u03b2 can also be removed via the blood-cerebrospinal fluid barrier, glymphatic drainage, and intramural periarterial drainage. This review discusses experimental approaches to increase cerebral A\u03b2 efflux via these mechanisms, clinical applications of these approaches, and findings in clinical trials with these approaches in patients with AD or mild cognitive impairment. Based on negative findings in clinical trials with previous approaches targeting monomeric A\u03b2, increasing the cerebral efflux of soluble A\u03b2 is unlikely to slow AD progression if used as monotherapy. But if used as an adjunct to treatment with lecanemab or donanemab, this approach might allow greater slowing of AD progression than treatment with either antibody alone.<\/jats:p>","DOI":"10.3233\/jad-240212","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T11:19:30Z","timestamp":1718363970000},"page":"379-411","source":"Crossref","is-referenced-by-count":11,"title":["Approaches for Increasing Cerebral Efflux of Amyloid-\u03b2 in Experimental Systems"],"prefix":"10.1177","volume":"100","author":[{"given":"David A.","family":"Loeffler","sequence":"first","affiliation":[{"name":"Department of Neurology, Beaumont Research Institute, Corewell Health, Royal Oak, MI, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-240212_ref1","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0165-6147(91)90609-V","article-title":"Amyloid deposition as the central event in the aetiology of Alzheimer\u2019s disease","volume":"12","author":"Hardy","year":"1991","journal-title":"Trends Pharmacol Sci"},{"key":"10.3233\/JAD-240212_ref2","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.3233\/JAD-240212_ref3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S0002-9440(10)65184-X","article-title":"Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer\u2019s disease","volume":"155","author":"Lue","year":"1999","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-240212_ref4","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1002\/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M","article-title":"Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer\u2019s disease","volume":"46","author":"McLean","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-240212_ref5","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/brain\/awt062","article-title":"Brain amyloid-\u03b2 oligomers in ageing and Alzheimer\u2019s disease","volume":"136 (Pt 5)","author":"Lesn\u00e9","year":"2013","journal-title":"Brain"},{"key":"10.3233\/JAD-240212_ref6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1126\/science.1079469","article-title":"Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis","volume":"300","author":"Kayed","year":"2003","journal-title":"Science"},{"key":"10.3233\/JAD-240212_ref7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nature04533","article-title":"A specific amyloid-beta protein assembly in the brain impairs memory","volume":"440","author":"Lesn\u00e9","year":"2006","journal-title":"Nature"},{"key":"10.3233\/JAD-240212_ref8","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1471-4159.2006.04426.x","article-title":"A beta oligomers - a decade of discovery","volume":"101","author":"Walsh","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref9","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1212\/01.WNL.0000159740.16984.3C","article-title":"Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial","volume":"64","author":"Gilman","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref10","doi-asserted-by":"crossref","first-page":"102","DOI":"10.5114\/aoms.2011.20612","article-title":"Tramiprosate in mild-to-moderate Alzheimer\u2019s disease - a randomized, double-blind, placebo-controlled, multi-centre study (the Alphase Study)","volume":"7","author":"Aisen","year":"2011","journal-title":"Arch Med Sci"},{"key":"10.3233\/JAD-240212_ref11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1002\/med.21622","article-title":"BACE1 inhibitors: Current status and future directions in treating Alzheimer\u2019s disease","volume":"40","author":"Moussa-Pacha","year":"2020","journal-title":"Med Res Rev"},{"key":"10.3233\/JAD-240212_ref12","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1001\/jama.2009.1866","article-title":"Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease: A randomized controlled trial","volume":"302","author":"Green","year":"2009","journal-title":"JAMA"},{"key":"10.3233\/JAD-240212_ref13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/13543784.2011.550572","article-title":"Therapeutic intervention for Alzheimer\u2019s disease with \u03b3-secretase inhibitors: Still a viable option?","volume":"20","author":"Imbimbo","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JAD-240212_ref14","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1586\/14737175.2014.945522","article-title":"Efficacy and safety studies of gantenerumab in patients with Alzheimer\u2019s disease","volume":"14","author":"Panza","year":"2014","journal-title":"Expert Rev Neurother"},{"key":"10.3233\/JAD-240212_ref15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-240212_ref16","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-240212_ref17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer\u2019s disease with lecanemab, an anti-A\u03b2 protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-240212_ref18","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer\u2019s disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-240212_ref19","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer\u2019s disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-240212_ref20","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: The TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.3233\/JAD-240212_ref21","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nature19323","article-title":"The antibody aducanumab reduces A\u03b2 plaques in Alzheimer\u2019s disease","volume":"537","author":"Sevigny","year":"2016","journal-title":"Nature"},{"key":"10.3233\/JAD-240212_ref22","first-page":"197","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer\u2019s disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref23","doi-asserted-by":"crossref","first-page":"n1682","DOI":"10.1136\/bmj.n1682","article-title":"Aducanumab for Alzheimer\u2019s disease?","volume":"374","author":"Walsh","year":"2021","journal-title":"BMJ"},{"key":"10.3233\/JAD-240212_ref25","first-page":"353","article-title":"Why physicians should not prescribe aducanumab for Alzheimer disease","volume":"105","author":"Ebell","year":"2022","journal-title":"Am Fam Physician"},{"key":"10.3233\/JAD-240212_ref26","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/d41586-022-03081-0","article-title":"Alzheimer\u2019s drug slows mental decline in trial - but is it a breakthrough?","volume":"610","author":"Prillaman","year":"2022","journal-title":"Nature"},{"key":"10.3233\/JAD-240212_ref27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.neuroimage.2018.10.011","article-title":"High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain","volume":"184","author":"Fang","year":"2019","journal-title":"Neuroimage"},{"key":"10.3233\/JAD-240212_ref28","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nn.4018","article-title":"Three dimensions of the amyloid hypothesis: Time, space and \u2018wingmen\u2019","volume":"18","author":"Musiek","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-240212_ref29","doi-asserted-by":"crossref","first-page":"hzu002","DOI":"10.1093\/biohorizons\/hzu002","article-title":"An effective treatment for Alzheimer\u2019s disease must consider both amyloid and tau","volume":"7","author":"Lansdall","year":"2014","journal-title":"Biosci Horizons"},{"key":"10.3233\/JAD-240212_ref30","doi-asserted-by":"crossref","first-page":"e12073","DOI":"10.1002\/trc2.12073","article-title":"Advancing combination therapy for Alzheimer\u2019s disease","volume":"6","author":"Salloway","year":"2020","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-240212_ref31","doi-asserted-by":"crossref","first-page":"4799","DOI":"10.1038\/s41467-020-18534-1","article-title":"Risk prediction of late-onset Alzheimer\u2019s disease implies an oligogenic architecture","volume":"11","author":"Zhang","year":"2020","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-240212_ref32","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1126\/science.1197623","article-title":"Decreased clearance of CNS beta-amyloid in Alzheimer\u2019s disease","volume":"330","author":"Mawuenyega","year":"2010","journal-title":"Science"},{"key":"10.3233\/JAD-240212_ref33","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1096\/fj.201700199RR","article-title":"Dysfunction of different cellular degradation pathways contributes to specific \u03b2-amyloid42-induced pathologies","volume":"32","author":"Ji","year":"2018","journal-title":"FASEB J"},{"key":"10.3233\/JAD-240212_ref34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.2174\/187152709787601867","article-title":"Clearance of amyloid-beta peptide across the blood-brain barrier: Implication for therapies in Alzheimer\u2019s disease","volume":"8","author":"Deane","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.3233\/JAD-240212_ref35","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/2045-8118-8-21","article-title":"Amyloid-beta transporter expression at the blood-CSF barrier is age-dependent","volume":"8,","author":"Pascale","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-240212_ref36","doi-asserted-by":"crossref","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","article-title":"Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain","volume":"33","author":"Iliff","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref37","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1750-3639.2008.00133.x","article-title":"Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer\u2019s disease","volume":"18","author":"Weller","year":"2008","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-240212_ref38","doi-asserted-by":"crossref","first-page":"475","DOI":"10.3389\/fnins.2017.00475","article-title":"Arterial pulsations cannot drive intramural periarterial drainage: Significance for A\u03b2 drainage","volume":"11","author":"Diem","year":"2017","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-240212_ref39","doi-asserted-by":"crossref","first-page":"e0205276","DOI":"10.1371\/journal.pone.0205276","article-title":"A control mechanism for intra-mural peri-arterial drainage via astrocytes: How neuronal activity could improve waste clearance from the brain","volume":"13","author":"Diem","year":"2018","journal-title":"PLoS One"},{"key":"10.3233\/JAD-240212_ref40","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00401-018-1862-7","article-title":"Convective influx\/glymphatic system: Tracers injected into the CSF enter and leave the brain along separate periarterial basement membrane pathways","volume":"136","author":"Albargothy","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fnagi.2019.00001","article-title":"Cerebrovascular smooth muscle cells as the drivers of intramural periarterial drainage of the brain","volume":"11","author":"Aldea","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-240212_ref42","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fnagi.2016.00223","article-title":"In vivo differential brain clearance and catabolism of monomeric and oligomeric Alzheimer\u2019s A\u03b2 protein","volume":"8","author":"McIntee","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-240212_ref43","doi-asserted-by":"crossref","first-page":"e1154641","DOI":"10.1080\/21688370.2016.1154641","article-title":"Junctional proteins of the blood-brain barrier: New insights into function and dysfunction","volume":"4","author":"Stamatovic","year":"2016","journal-title":"Tissue Barriers"},{"key":"10.3233\/JAD-240212_ref44","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1023\/A:1006995910836","article-title":"Tight junctions of the blood-brain barrier","volume":"20","author":"Kniesel","year":"2000","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-240212_ref45","doi-asserted-by":"crossref","first-page":"a020412","DOI":"10.1101\/cshperspect.a020412","article-title":"The blood-brain barrier","volume":"7","author":"Daneman","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.3233\/JAD-240212_ref46","doi-asserted-by":"crossref","first-page":"914","DOI":"10.3389\/fphys.2020.00914","article-title":"Structure, function, and regulation of the blood-brain barrier tight junction in central nervous system disorders","volume":"11","author":"Lochhead","year":"2020","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-240212_ref47","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1152\/physrev.00035.2003","article-title":"Endothelial cell-to-cell junctions: Molecular organization and role in vascular homeostasis","volume":"84","author":"Bazzoni","year":"2004","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-240212_ref48","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/nm.3407","article-title":"Development, maintenance and disruption of the blood-brain barrier","volume":"19","author":"Obermeier","year":"2013","journal-title":"Nat Med"},{"key":"10.3233\/JAD-240212_ref49","doi-asserted-by":"crossref","first-page":"3413","DOI":"10.1038\/ncomms4413","article-title":"Astrocytic laminin regulates pericyte differentiation and maintains blood brain barrier integrity","volume":"5","author":"Yao","year":"2014","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-240212_ref50","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/bpa.12759","article-title":"Cerebrovascular miRNAs correlate with the clearance of A\u03b2 through perivascular route in younger 3xTg-AD mice","volume":"30","author":"Fu","year":"2020","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-240212_ref51","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/jcmm.13980","article-title":"Age-related ultrastructural changes of the basement membrane in the mouse blood-brain barrier","volume":"23","author":"Ceafalan","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.3233\/JAD-240212_ref52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3389\/fnagi.2019.00196","article-title":"Age-related functional and expressional changes in efflux pathways at the blood-brain barrier","volume":"11","author":"Erd\u0151","year":"2019","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-240212_ref53","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0301-0082(00)00068-X","article-title":"Cerebral microvascular pathology in aging and Alzheimer\u2019s disease","volume":"64","author":"Farkas","year":"2001","journal-title":"Prog Neurobiol"},{"key":"10.3233\/JAD-240212_ref54","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.matbio.2010.03.004","article-title":"Age-dependent changes in the structure, composition and biophysical properties of a human basement membrane","volume":"29","author":"Candiello","year":"2010","journal-title":"Matrix Biol"},{"key":"10.3233\/JAD-240212_ref55","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.neuropharm.2014.01.023","article-title":"Differences in amyloid-\u03b2 clearance across mouse and human blood-brain barrier models: Kinetic analysis and mechanistic modeling","volume":"79","author":"Qosa","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.3233\/JAD-240212_ref56","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s12975-019-00755-2","article-title":"From stroke to dementia: A comprehensive review exposing tight interactions between stroke and amyloid-\u03b2 formation","volume":"11","author":"Goulay","year":"2020","journal-title":"Transl Stroke Res"},{"key":"10.3233\/JAD-240212_ref57","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/ana.24270","article-title":"Amyloid-\u03b2 efflux from the central nervous system into the plasma","volume":"76","author":"Roberts","year":"2014","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-240212_ref58","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/j.neuron.2014.01.045","article-title":"ApoE and A\u03b2 in Alzheimer\u2019s disease: Accidental encounters or partners?","volume":"81","author":"Kanekiyo","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-240212_ref59","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI57867","article-title":"Cerebral amyloid-\u03b2 proteostasis is regulated by the membrane transport protein ABCC1 in mice","volume":"121","author":"Krohn","year":"2011","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-240212_ref60","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1177\/1073858420954811","article-title":"Cerebral amyloid angiopathy and blood-brain barrier dysfunction","volume":"27","author":"Gireud-Goss","year":"2020","journal-title":"Neuroscientist"},{"key":"10.3233\/JAD-240212_ref61","doi-asserted-by":"crossref","first-page":"e1500472","DOI":"10.1126\/sciadv.1500472","article-title":"Autoregulated paracellular clearance of amyloid-\u03b2 across the blood-brain barrier","volume":"1","author":"Keaney","year":"2015","journal-title":"Sci Adv"},{"key":"10.3233\/JAD-240212_ref62","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/sj.jcbfm.9600419","article-title":"Transport pathways for clearance of human Alzheimer\u2019s amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system","volume":"27","author":"Bell","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-240212_ref63","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1111\/j.1471-4159.2007.04938.x","article-title":"Cerebral clearance of human amyloid-beta peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes","volume":"103","author":"Ito","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref64","doi-asserted-by":"crossref","first-page":"e13258","DOI":"10.1111\/acel.13258","article-title":"Alzheimer\u2019s amyloid \u03b2 heterogeneous species differentially affect brain endothelial cell viability, blood-brain barrier integrity, and angiogenesis","volume":"19","author":"Parodi-Rull\u00e1n","year":"2020","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-240212_ref65","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nat Med"},{"key":"10.3233\/JAD-240212_ref66","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bbi.2018.07.017","article-title":"The concerted amyloid-beta clearance of LRP1 and ABCB1\/P-gp across the blood-brain barrier is linked by PICALM","volume":"73","author":"Storck","year":"2018","journal-title":"Brain Behav Immun"},{"key":"10.3233\/JAD-240212_ref67","doi-asserted-by":"crossref","first-page":"695479","DOI":"10.3389\/fncel.2021.695479","article-title":"Relationship between amyloid-\u03b2 deposition and blood-brain barrier dysfunction in Alzheimer\u2019s disease","volume":"15","author":"Wang","year":"2021","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-240212_ref68","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1111\/j.1471-4159.2010.06708.x","article-title":"Lack of brain-to-blood efflux transport activity of low-density lipoprotein receptor-related protein-1 (LRP-1) for amyloid-beta peptide(1-40) in mouse: Involvement of an LRP-1-independent pathway","volume":"113","author":"Ito","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref69","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer\u2019s amyloid-\u03b2(1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-240212_ref70","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.neurobiolaging.2008.02.002","article-title":"Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: A possible role in progressive neurodegeneration","volume":"30","author":"Bartels","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref71","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2017.05.011","article-title":"Aging alters mRNA expression of amyloid transporter genes at the blood-brain barrier","volume":"57","author":"Osgood","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref72","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI11013","article-title":"Modulation of amyloid beta-protein clearance and Alzheimer\u2019s disease susceptibility by the LDL receptor-related protein pathway","volume":"106","author":"Kang","year":"2000","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-240212_ref73","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.brainres.2010.08.034","article-title":"ABC efflux transporters in brain vasculature of Alzheimer\u2019s subjects","volume":"1358","author":"Wijesuriya","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-240212_ref74","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1093\/brain\/awu046","article-title":"Regional distribution of synaptic markers and APP correlate with distinct clinicopathological features in sporadic and familial Alzheimer\u2019s disease","volume":"137","author":"Shinohara","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-240212_ref75","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.neurobiolaging.2015.05.020","article-title":"P-glycoprotein expression and amyloid accumulation in human aging and Alzheimer\u2019s disease: Preliminary observations","volume":"36","author":"Chiu","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref76","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/NEN.0b013e3181f52e01","article-title":"Distribution and expression of picalm in Alzheimer disease","volume":"69","author":"Baig","year":"2010","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-240212_ref77","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/nn.4025","article-title":"Central role for PICALM in amyloid-\u03b2 blood-brain barrier transcytosis and clearance","volume":"18","author":"Zhao","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-240212_ref78","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.freeradbiomed.2010.09.013","article-title":"Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for A\u03b2 accumulation in AD brain","volume":"49","author":"Owen","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.3233\/JAD-240212_ref79","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","article-title":"Low-density lipoprotein receptor-related protein-1: A serial clearance homeostatic mechanism controlling Alzheimer\u2019s amyloid beta-peptide elimination from the brain","volume":"115","author":"Zlokovic","year":"2010","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref80","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1194\/jlr.R075796","article-title":"Role of LRP1 in the pathogenesis of Alzheimer\u2019s disease: Evidence from clinical and preclinical studies","volume":"58","author":"Shinohara","year":"2017","journal-title":"J Lipid Res"},{"key":"10.3233\/JAD-240212_ref81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2012.07.008","article-title":"Low-density lipoprotein receptor-related protein 1: A physiological A\u03b2 homeostatic mechanism with multiple therapeutic opportunities","volume":"136","author":"Sagare","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.3233\/JAD-240212_ref82","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.1172\/JCI36663","article-title":"apoE isoform-specific disruption of amyloid beta peptide clearance from mouse brain","volume":"118","author":"Deane","year":"2008","journal-title":"J Clin Invest"},{"key":"10.3233\/JAD-240212_ref83","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-240212_ref84","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/jnc.12484","article-title":"Blocking the apolipoprotein E\/amyloid \u03b2 interaction in triple transgenic mice ameliorates Alzheimer\u2019s disease related amyloid \u03b2 and tau pathology","volume":"128","author":"Liu","year":"2014","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref85","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-018-0286-0","article-title":"Blood-brain barrier-associated pericytes internalize and clear aggregated amyloid-\u03b242 by LRP1-dependent apolipoprotein E isoform-specific mechanism","volume":"13","author":"Ma","year":"2018","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240212_ref86","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00401-009-0522-3","article-title":"Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer\u2019s disease","volume":"118","author":"Bell","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref87","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fphys.2013.00045","article-title":"The role of ABCB1 and ABCA1 in beta-amyloid clearance at the neurovascular unit in Alzheimer\u2019s disease","volume":"4","author":"Elali","year":"2013","journal-title":"Front Physiol"},{"key":"10.3233\/JAD-240212_ref88","doi-asserted-by":"crossref","first-page":"41197","DOI":"10.1074\/jbc.M407962200","article-title":"Deficiency of ABCA1 impairs apolipoprotein E metabolism in brain","volume":"279","author":"Hirsch-Reinshagen","year":"2004","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-240212_ref89","doi-asserted-by":"crossref","first-page":"164","DOI":"10.3389\/fnins.2019.00164","article-title":"Clusterin in Alzheimer\u2019s disease: Mechanisms, genetics, and lessons from other pathologies","volume":"13","author":"Foster","year":"2019","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-240212_ref90","doi-asserted-by":"crossref","first-page":"8681","DOI":"10.1073\/pnas.1711357114","article-title":"Role of clusterin in the brain vascular clearance of amyloid-\u03b2","volume":"114","author":"Nelson","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref91","doi-asserted-by":"crossref","first-page":"18644","DOI":"10.1074\/jbc.272.30.18644","article-title":"Interaction of apolipoprotein J-amyloid \u03b2-peptide complex with low density lipoprotein receptor-related protein-2\/megalin. A mechanism to prevent pathological accumulation of amyloid \u03b2-peptide","volume":"272","author":"Hammad","year":"1997","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-240212_ref92","doi-asserted-by":"crossref","first-page":"E6962","DOI":"10.1073\/pnas.1701137114","article-title":"Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways","volume":"114","author":"Wojtas","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref93","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s13024-020-00416-1","article-title":"Astrocyte-derived clusterin suppresses amyloid formation in vivo","volume":"15","author":"Wojtas","year":"2020","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240212_ref94","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1096\/fj.06-7986com","article-title":"The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures","volume":"21","author":"Yerbury","year":"2007","journal-title":"FASEB J"},{"key":"10.3233\/JAD-240212_ref95","doi-asserted-by":"crossref","first-page":"9270","DOI":"10.1021\/bi301277k","article-title":"Amyloid-\u03b2 oligomers are sequestered by both intracellular and extracellular chaperones","volume":"51","author":"Narayan","year":"2012","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-240212_ref96","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/ng.440","article-title":"Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer\u2019s disease","volume":"41","author":"Harold","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-240212_ref97","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1038\/ng.439","article-title":"Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer\u2019s disease","volume":"41","author":"Lambert","year":"2009","journal-title":"Nat Genet"},{"key":"10.3233\/JAD-240212_ref98","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0896-6273(90)90342-D","article-title":"Dynamics of gene expression for a hippocampal glycoprotein elevated in Alzheimer\u2019s disease and in response to experimental lesions in rat","volume":"5","author":"May","year":"1990","journal-title":"Neuron"},{"key":"10.3233\/JAD-240212_ref99","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00441-014-1811-2","article-title":"Novel insights into the development and maintenance of the blood-brain barrier","volume":"355","author":"Engelhardt","year":"2014","journal-title":"Cell Tissue Res"},{"key":"10.3233\/JAD-240212_ref100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00401-018-1815-1","article-title":"Functional morphology of the blood-brain barrier in health and disease","volume":"135","author":"Liebner","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref101","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.neuint.2014.05.004","article-title":"Dysfunctional Wnt\/\u03b2-catenin signaling contributes to blood-brain barrier breakdown in Alzheimer\u2019s disease","volume":"75","author":"Liu","year":"2014","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-240212_ref102","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13041-019-0525-5","article-title":"Restoring Wnt\/\u03b2-catenin signaling is a promising therapeutic strategy for Alzheimer\u2019s disease","volume":"12","author":"Jia","year":"2019","journal-title":"Mol Brain"},{"key":"10.3233\/JAD-240212_ref103","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuron.2014.08.048","article-title":"Deficiency in LRP6-mediated Wnt signaling contributes to synaptic abnormalities and amyloid pathology in Alzheimer\u2019s disease","volume":"84","author":"Liu","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-240212_ref104","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s12987-016-0038-x","article-title":"Inhibition of ADAM10 promotes the clearance of A\u03b2 across the BBB by reducing LRP1 ectodomain shedding","volume":"13","author":"Shackleton","year":"2016","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-240212_ref105","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s42003-022-04398-2","article-title":"A\u03b2 efflux impairment and inflammation linked to cerebrovascular accumulation of amyloid-forming amylin secreted from pancreas","volume":"6","author":"Verma","year":"2023","journal-title":"Commun Biol"},{"key":"10.3233\/JAD-240212_ref106","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1073\/pnas.1209362110","article-title":"Identification of an essential endogenous regulator of blood-brain barrier integrity, and its pathological and therapeutic implications","volume":"110","author":"Cristante","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref107","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1093\/brain\/awab050","article-title":"Annexin A1 restores cerebrovascular integrity concomitant with reduced amyloid-\u03b2 and tau pathology","volume":"144","author":"Ries","year":"2021","journal-title":"Brain"},{"key":"10.3233\/JAD-240212_ref108","doi-asserted-by":"crossref","first-page":"148518","DOI":"10.1016\/j.brainres.2023.148518","article-title":"Astaxanthin enhances autophagy, amyloid beta clearance and exerts anti-inflammatory effects in in vitro models of Alzheimer\u2019s disease-related blood brain barrier dysfunction and inflammation","volume":"1819","author":"Babalola","year":"2023","journal-title":". Brain Res"},{"key":"10.3233\/JAD-240212_ref109","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/ptr.6043","article-title":"Catalpol provides a protective effect on fibrillary A\u03b21-42 -induced barrier disruption in an in vitro model of the blood-brain barrier","volume":"32","author":"Liu","year":"2018","journal-title":"Phytother Res"},{"key":"10.3233\/JAD-240212_ref110","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.3390\/pharmaceutics15082084","article-title":"Cu(ATSM) increases P-glycoprotein expression and function at the blood-brain barrier in C57BL6\/J mice","volume":"15","author":"Pyun","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.3233\/JAD-240212_ref111","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2119\/molmed.2010.00180","article-title":"Selective antihypertensive dihydropyridines lower A\u03b2 accumulation by targeting both the production and the clearance of A\u03b2 across the blood-brain barrier","volume":"17","author":"Paris","year":"2011","journal-title":"Mol Med"},{"key":"10.3233\/JAD-240212_ref112","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2045-8118-8-20","article-title":"1\u03b1,25-Dihydroxyvitamin D3 enhances cerebral clearance of human amyloid-\u03b2 peptide(1-40) from mouse brain across the blood-brain barrier","volume":"8","author":"Ito","year":"2011","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-240212_ref113","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jns.2018.01.019","article-title":"Transplantation of in vitro cultured endothelial progenitor cells repairs the blood-brain barrier and improves cognitive function of APP\/PS1 transgenic AD mice","volume":"387","author":"Zhang","year":"2018","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-240212_ref114","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.nbd.2016.06.003","article-title":"Late running is not too late against Alzheimer\u2019s pathology","volume":"94","author":"Herring","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-240212_ref115","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/j.jalz.2016.05.006","article-title":"Kallikrein-8 inhibition attenuates Alzheimer\u2019s disease pathology in mice","volume":"12","author":"Herring","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240212_ref116","doi-asserted-by":"crossref","first-page":"15502","DOI":"10.1073\/pnas.1206446109","article-title":"Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood A\u03b2 clearance in a mouse model of \u03b2-amyloidosis","volume":"109","author":"Castellano","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref117","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.neuroscience.2019.04.018","article-title":"Intravenous infusion of mesenchymal stem cells improves impaired cognitive function in a cerebral small vessel disease model","volume":"408","author":"Nakazaki","year":"2019","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-240212_ref118","doi-asserted-by":"crossref","first-page":"8296","DOI":"10.1007\/s12035-019-01672-z","article-title":"Influence of matrix metallopeptidase 9 on beta-amyloid elimination across the blood-brain barrier","volume":"56","author":"Shackleton","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-240212_ref119","doi-asserted-by":"crossref","first-page":"767","DOI":"10.3233\/JAD-131091","article-title":"Increased efflux of amyloid-\u03b2 peptides through the blood-brain barrier by muscarinic acetylcholine receptor inhibition reduces pathological phenotypes in mouse models of brain amyloidosis","volume":"38","author":"Paganetti","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref120","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3390\/ijms23031019","article-title":"The ubiquitin E3 ligase Nedd4 regulates the expression and amyloid-\u03b2 peptide export activity of P-glycoprotein","volume":"23","author":"Chai","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref121","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1021\/acschemneuro.2c00005","article-title":"Oleuropein-rich olive leaf extract attenuates neuroinflammation in the Alzheimer\u2019s disease mouse model","volume":"13","author":"Abdallah","year":"2022","journal-title":"ACS Chem Neurosci"},{"key":"10.3233\/JAD-240212_ref122","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-023-00597-5","article-title":"Anti-malaria drug artesunate prevents development of amyloid-\u03b2 pathology in mice by upregulating PICALM at the blood-brain barrier","volume":"18","author":"Kisler","year":"2023","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240212_ref123","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/s00018-022-04237-x","article-title":"PCSK9 acts as a key regulator of A\u03b2 clearance across the blood-brain barrier","volume":"79","author":"Mazura","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-240212_ref124","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s12035-018-1045-5","article-title":"Somatostatin maintains permeability and integrity of blood-brain barrier in \u03b2-amyloid induced toxicity","volume":"56","author":"Paik","year":"2019","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-240212_ref125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.neuroscience.2018.03.028","article-title":"Characterization of hit compounds identified from high-throughput screening for their effect on blood-brain barrier integrity and amyloid-\u03b2 clearance: In vitro and in vivo studies","volume":"379","author":"Elfakhri","year":"2018","journal-title":"Neuroscience"},{"key":"10.3233\/JAD-240212_ref126","doi-asserted-by":"crossref","first-page":"e8300","DOI":"10.15252\/emmm.201708300","article-title":"Counteracting the effects of TNF receptor-1 has therapeutic potential in Alzheimer\u2019s disease","volume":"10","author":"Steeland","year":"2018","journal-title":"EMBO Mol Med"},{"key":"10.3233\/JAD-240212_ref127","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1152\/physrev.00004.2013","article-title":"Cerebrospinal fluid secretion by the choroid plexus","volume":"93","author":"Damkier","year":"2013","journal-title":"Physiol Rev"},{"key":"10.3233\/JAD-240212_ref128","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/1097-0029(20010101)52:1<49::AID-JEMT7>3.0.CO;2-C","article-title":"Mechanisms of CSF secretion by the choroid plexus","volume":"52","author":"Speake","year":"2001","journal-title":"Microsc Res Tech"},{"key":"10.3233\/JAD-240212_ref129","doi-asserted-by":"crossref","first-page":"s515","DOI":"10.2741\/1085","article-title":"Choroid plexus, aging of the brain, and Alzheimer\u2019s disease","volume":"8","author":"Serot","year":"2003","journal-title":"Front Biosci"},{"key":"10.3233\/JAD-240212_ref130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0070-2153(05)71001-2","article-title":"The choroid plexus-cerebrospinal fluid system: From development to aging","volume":"71","author":"Redzic","year":"2005","journal-title":"Curr Top Dev Biol"},{"key":"10.3233\/JAD-240212_ref131","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2202-12-39","article-title":"The p75 neurotrophin receptor localization in blood-CSF barrier: Expression in choroid plexus epithelium","volume":"12","author":"Spuch","year":"2011","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-240212_ref132","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3389\/fphar.2012.00075","article-title":"Pathological alteration in the choroid plexus of Alzheimer\u2019s disease: Implication for new therapy approaches","volume":"3","author":"Krzyzanowska","year":"2012","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-240212_ref133","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3233\/JAD-181179","article-title":"Choroid plexus acts as gatekeeper for TREM2, abnormal accumulation of ApoE, and fibrillary tau in Alzheimer\u2019s disease and in Down syndrome dementia","volume":"69","author":"Raha-Chowdhury","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref134","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neubiorev.2021.04.025","article-title":"Application of contrast-enhanced magnetic resonance imaging in the assessment of blood-cerebrospinal fluid barrier integrity","volume":"127","author":"Verheggen","year":"2021","journal-title":"Neurosci Biobehav Rev"},{"key":"10.3233\/JAD-240212_ref135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fnmol.2019.00034","article-title":"Clinical imaging of choroid plexus in health and in brain disorders: A mini-review","volume":"12","author":"Hubert","year":"2019","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-240212_ref136","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0165-3806(90)90163-S","article-title":"A morphometric study on the development of the lateral ventricle choroid plexus, choroid plexus capillaries and ventricular ependyma in the rat","volume":"56","author":"Keep","year":"1990","journal-title":"Brain Res"},{"key":"10.3233\/JAD-240212_ref137","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/jnen\/59.7.561","article-title":"Choroid plexus in the central nervous system: Biology and physiopathology","volume":"59","author":"Strazielle","year":"2000","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-240212_ref138","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/jnen\/nlv030","article-title":"The choroid plexus in healthy and diseased brain","volume":"75","author":"Kaur","year":"2016","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-240212_ref139","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1750-1326-8-38","article-title":"Blood-brain-barriers in aging and in Alzheimer\u2019s disease","volume":"8","author":"Marques","year":"2013","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240212_ref140","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00401-018-1807-1","article-title":"Molecular anatomy and functions of the choroidal blood-cerebrospinal fluid barrier in health and disease","volume":"135","author":"Ghersi-Egea","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref141","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4103\/1673-5374.180372","article-title":"The choroid plexus-cerebrospinal fluid interface in Alzheimer\u2019s disease: More than just a barrier","volume":"11","author":"Balusu","year":"2016","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-240212_ref142","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3389\/fncel.2015.00017","article-title":"Choroid plexus dysfunction impairs beta-amyloid clearance in a triple transgenic mouse model of Alzheimer\u2019s disease","volume":"9","author":"Gonz\u00e1lez-Marrero","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-240212_ref143","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1007045605751","article-title":"The choroid plexuses and the barriers between the blood and the cerebrospinal fluid","volume":"20","author":"Segal","year":"2000","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-240212_ref144","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S0197-4580(01)00317-7","article-title":"Substitution at codon 22 reduces clearance of Alzheimer\u2019s amyloid-beta peptide from the cerebrospinal fluid and prevents its transport from the central nervous system into blood","volume":"23","author":"Monro","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref145","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/153537020523001011","article-title":"The choroid plexus removes beta-amyloid from brain cerebrospinal fluid","volume":"230","author":"Crossgrove","year":"2005","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.3233\/JAD-240212_ref146","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.brainres.2006.12.022","article-title":"Macromolecules involved in production and metabolism of beta-amyloid at the brain barriers","volume":"1138","author":"Crossgrove","year":"2007","journal-title":"Brain Res"},{"key":"10.3233\/JAD-240212_ref147","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0006-8993(99)01466-3","article-title":"Biondi ring tangles in the choroid plexus of Alzheimer\u2019s disease and normal aging brains: A quantitative study","volume":"832","author":"Wen","year":"1999","journal-title":"Brain Res"},{"key":"10.3233\/JAD-240212_ref148","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.0953-816x.2001.01693.x","article-title":"Choroid plexus and ageing in rats: A morphometric and ultrastructural study","volume":"14","author":"Serot","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.3233\/JAD-240212_ref149","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0047-6374(87)90054-6","article-title":"Enzyme histochemistry of the choroid plexus in old rats","volume":"41","author":"Ferrante","year":"1987","journal-title":"Mech Ageing Dev"},{"key":"10.3233\/JAD-240212_ref150","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.40.3_Part_1.500","article-title":"Cerebrospinal fluid production is reduced in healthy aging","volume":"8","author":"May","year":"1990","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref151","first-page":"81","article-title":"A comparative ultracytochemical and biochemical study of the ATPases of the choroid plexus in aging","volume":"34","author":"Kvitnitskaia-Ryzhova","year":"1992","journal-title":"Tsitologiia"},{"key":"10.3233\/JAD-240212_ref152","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/1097-0029(20010101)52:1<31::AID-JEMT5>3.0.CO;2-T","article-title":"Ageing choroid plexus-cerebrospinal fluid system","volume":"52","author":"Preston","year":"2001","journal-title":"Microsc Res Tech"},{"key":"10.3233\/JAD-240212_ref153","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.exger.2008.12.004","article-title":"Age-related changes in choroid plexus and blood-cerebrospinal fluid barrier function in the sheep","volume":"44","author":"Chen","year":"2009","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-240212_ref154","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00234-013-1290-2","article-title":"Measurement of choroid plexus perfusion using dynamic susceptibility MR imaging: Capillary permeability and age-related changes","volume":"55","author":"Bouzerar","year":"2013","journal-title":"Neuroradiology"},{"key":"10.3233\/JAD-240212_ref155","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1600-0404.1994.tb02647.x","article-title":"Cerebrospinal fluid production and dynamics in normal aging: A MRI phase-mapping study","volume":"89","author":"Gideon","year":"1994","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-240212_ref156","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1743-8454-6-11","article-title":"Involvement of insulin-degrading enzyme in the clearance of beta-amyloid at the blood-CSF barrier: Consequences of lead exposure","volume":"6","author":"Behl","year":"2009","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.3233\/JAD-240212_ref157","first-page":"295","article-title":"Immunodistribution of amyloid beta protein (A\u03b2) and advanced glycation end-product receptors (RAGE) in choroid plexus and ependyma of resuscitated patients","volume":"49","author":"Ma\u015bli\u0144ska","year":"2011","journal-title":"Folia Neuropathol"},{"key":"10.3233\/JAD-240212_ref158","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/PL00007412","article-title":"Morphological alterations of the choroid plexus in late-onset Alzheimer\u2019s disease","volume":"99","author":"Serot","year":"2000","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref159","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1743-8454-1-3","article-title":"Homeostatic capabilities of the choroid plexus epithelium in Alzheimer\u2019s disease","volume":"1","author":"Johanson","year":"2004","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.3233\/JAD-240212_ref160","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0046-8177(94)90035-3","article-title":"Comparative immunohistochemical characteristics of human choroid plexus in vascular and Alzheimer\u2019s dementia","volume":"25","author":"Serot","year":"1994","journal-title":"Hum Pathol"},{"key":"10.3233\/JAD-240212_ref161","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s12987-018-0120-7","article-title":"Choroid plexus genes for CSF production and brain homeostasis are altered in Alzheimer\u2019s disease","volume":"15","author":"Kant","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-240212_ref162","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12987-018-0102-9","article-title":"Comparative transcriptomics of choroid plexus in Alzheimer\u2019s disease, frontotemporal dementia and Huntington\u2019s disease: Implications for CSF homeostasis","volume":"15","author":"Stopa","year":"2018","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-240212_ref163","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1212\/WNL.57.2.260","article-title":"Mitochondrial enzyme-deficient hippocampal neurons and choroidal cells in AD","volume":"57","author":"Cottrell","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref164","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1016\/j.neurobiolaging.2008.08.017","article-title":"Abeta accumulation in choroid plexus is associated with mitochondrial-induced apoptosis","volume":"31","author":"Vargas","year":"2010","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref165","doi-asserted-by":"crossref","first-page":"5608","DOI":"10.1016\/j.biomaterials.2010.03.042","article-title":"The effect of encapsulated VEGF-secreting cells on brain amyloid load and behavioral impairment in a mouse model of Alzheimer\u2019s disease","volume":"31","author":"Spuch","year":"2010","journal-title":"Biomaterials"},{"key":"10.3233\/JAD-240212_ref166","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF02279767","article-title":"Integrity of the blood-CSF barrier in dementia of Alzheimer type: CSF\/serum ratios of albumin and IgG","volume":"240","author":"Fr\u00f6lich","year":"1991","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-240212_ref167","first-page":"348","article-title":"Evidence of blood-cerebrospinal fluid-barrier impairment in a subgroup of patients with dementia of the Alzheimer type and major depression: A possible indicator for immunoactivation","volume":"6","author":"Hampel","year":"1995","journal-title":"Dementia"},{"key":"10.3233\/JAD-240212_ref168","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00401-009-0574-4","article-title":"Oxidative stress damage and oxidative stress responses in the choroid plexus in Alzheimer\u2019s disease","volume":"118","author":"Perez-Gracia","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref169","doi-asserted-by":"crossref","first-page":"12766","DOI":"10.1523\/JNEUROSCI.0006-15.2015","article-title":"Amyloid \u03b2 oligomers disrupt blood-CSF barrier integrity by activating matrix metalloproteinases","volume":"35","author":"Brkic","year":"2015","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref170","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","article-title":"The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer\u2019s type","volume":"57","author":"Silverberg","year":"2001","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref171","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1743-8454-5-10","article-title":"Multiplicity of cerebrospinal fluid functions: New challenges in health and disease","volume":"5","author":"Johanson","year":"2008","journal-title":"Cerebrospinal Fluid Res"},{"key":"10.3233\/JAD-240212_ref172","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1474-4422(03)00487-3","article-title":"Alzheimer\u2019s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: A hypothesis","volume":"2","author":"Silverberg","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-240212_ref173","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1326-4-17","article-title":"LRP1 shedding in human brain: Roles of ADAM10 and ADAM17","volume":"4","author":"Liu","year":"2009","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240212_ref174","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2174\/1874609811003030219","article-title":"Clearance of amyloid-\u03b2 peptide across the choroid plexus in Alzheimer\u2019s disease","volume":"3","author":"Alvira-Botero","year":"2010","journal-title":"Curr Aging Sci"},{"key":"10.3233\/JAD-240212_ref175","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fncel.2015.00134","article-title":"Soluble megalin is reduced in cerebrospinal fluid samples of Alzheimer\u2019s disease patients","volume":"9","author":"Spuch","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-240212_ref176","doi-asserted-by":"crossref","first-page":"8672","DOI":"10.3390\/ijms21228672","article-title":"Transthyretin stabilization: An emerging strategy for the treatment of Alzheimer\u2019s disease?","volume":"21","author":"Saponaro","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref177","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1210\/endo-63-2-256","article-title":"Pre-albumin: A thyroxinebinding protein of human plasma","volume":"63","author":"Ingbar","year":"1958","journal-title":"Endocrinology"},{"key":"10.3233\/JAD-240212_ref178","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1016\/S0021-9258(18)93118-2","article-title":"The interaction of thyroxine with human plasma prealbumin and with the prealbumin-retinol-binding protein complex","volume":"244","author":"Raz","year":"1969","journal-title":"J Biol Chem"},{"key":"10.3233\/JAD-240212_ref179","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s10571-008-9339-1","article-title":"17beta-estradiol induces transthyretin expression in murine choroid plexus via an oestrogen receptor dependent pathway","volume":"29","author":"Quintela","year":"2009","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-240212_ref180","doi-asserted-by":"crossref","first-page":"20164","DOI":"10.1038\/srep20164","article-title":"Transthyretin participates in beta-amyloid transport from the brain to the liver\u2013involvement of the low-density lipoprotein receptor-related protein 1?","volume":"6","author":"Alemi","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-240212_ref181","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/ijms21062075","article-title":"Undiscovered roles for transthyretin: From a transporter protein to a new therapeutic target for Alzheimer\u2019s Disease","volume":"21","author":"Gi\u00e3o","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref182","doi-asserted-by":"crossref","first-page":"8368","DOI":"10.1073\/pnas.91.18.8368","article-title":"Transthyretin sequesters amyloid beta protein and prevents amyloid formation","volume":"91","author":"Schwarzman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref183","first-page":"146","article-title":"Interaction of transthyretin with amyloid beta-protein: Binding and inhibition of amyloid formation","volume":"199","author":"Schwarzman","year":"1996","journal-title":"Ciba Found Symp"},{"key":"10.3233\/JAD-240212_ref184","doi-asserted-by":"crossref","first-page":"413","DOI":"10.3233\/JAD-2004-6409","article-title":"Estrogen increases brain expression of the mRNA encoding transthyretin, an amyloid beta scavenger protein","volume":"6","author":"Tang","year":"2004","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref185","doi-asserted-by":"crossref","first-page":"8276","DOI":"10.1021\/bi101280t","article-title":"Characterization of the interaction of \u03b2-amyloid with transthyretin monomers and tetramers","volume":"49","author":"Du","year":"2010","journal-title":"Biochemistry"},{"key":"10.3233\/JAD-240212_ref186","doi-asserted-by":"crossref","first-page":"19423","DOI":"10.1523\/JNEUROSCI.2561-13.2013","article-title":"Mechanisms of transthyretin inhibition of \u03b2-amyloid aggregation in vitro","volume":"33","author":"Li","year":"2013","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref187","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/j.1471-4159.2007.04828.x","article-title":"Transthyretin enhances nerve regeneration","volume":"103","author":"Fleming","year":"2007","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref188","first-page":"1188","article-title":"Transthyretin represses neovascularization in diabetic retinopathy","volume":"22","author":"Shao","year":"2016","journal-title":"Mol Vis"},{"key":"10.3233\/JAD-240212_ref189","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3233\/JAD-2009-0966","article-title":"Reduced levels of amyloid-beta-binding proteins in cerebrospinal fluid from Alzheimer\u2019s disease patients","volume":"16","author":"Hansson","year":"2009","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref190","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1186\/s12864-015-2159-z","article-title":"Gene expression and functional annotation of human choroid plexus epithelium failure in Alzheimer\u2019s disease","volume":"16","author":"Bergen","year":"2015","journal-title":"BMC Genomics"},{"key":"10.3233\/JAD-240212_ref191","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fncel.2015.00080","article-title":"The choroid plexus-a multi-role player during infectious diseases of the CNS","volume":"9","author":"Schwerk","year":"2015","journal-title":"Front Cell Neurosci"},{"key":"10.3233\/JAD-240212_ref192","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1001\/archneur.61.5.668","article-title":"Inflammatory proteins in plasma and the risk of dementia: The rotterdam study","volume":"61","author":"Engelhart","year":"2004","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-240212_ref193","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1212\/01.wnl.0000263217.36439.da","article-title":"Inflammatory markers and the risk of Alzheimer disease: The Framingham Study","volume":"68","author":"Tan","year":"2007","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref194","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.imlet.2008.02.002","article-title":"Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer\u2019s disease","volume":"117","author":"Bermejo","year":"2008","journal-title":"Immunol Lett"},{"key":"10.3233\/JAD-240212_ref195","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s40478-021-01253-z","article-title":"Low-grade peripheral inflammation affects brain pathology in the AppNL-G-Fmouse model of Alzheimer\u2019s disease","volume":"9","author":"Xie","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-240212_ref196","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1523\/JNEUROSCI.0967-12.2012","article-title":"Matrix metalloprotease 8-dependent extracellular matrix cleavage at the blood-CSF barrier contributes to lethality during systemic inflammatory diseases","volume":"32","author":"Vandenbroucke","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref197","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1007\/s00018-013-1529-4","article-title":"Choroid plexus implants rescue Alzheimer\u2019s disease-like pathologies by modulating amyloid-\u03b2 degradation","volume":"71","author":"Bolos","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-240212_ref198","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s12031-015-0492-y","article-title":"Encapsulated choroid plexus epithelial cells actively protect against intrahippocampal A\u03b2-induced long-term memory dysfunction: Upregulation of effective neurogenesis with the abrogated apoptosis and neuroinflammation","volume":"56","author":"Aliaghaei","year":"2015","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-240212_ref199","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2202-10-110","article-title":"Regulation of cerebrospinal fluid production by caffeine consumption","volume":"10","author":"Han","year":"2009","journal-title":"BMC Neurosci"},{"key":"10.3233\/JAD-240212_ref200","doi-asserted-by":"crossref","first-page":"11","DOI":"10.4137\/PMC.S6509","article-title":"Choroidal proteins involved in cerebrospinal fluid production may be potential drug targets for Alzheimer\u2019s disease therapy","volume":"5","author":"Wostyn","year":"2011","journal-title":"Perspect Medicin Chem"},{"key":"10.3233\/JAD-240212_ref201","doi-asserted-by":"crossref","first-page":"100149","DOI":"10.1016\/j.bbih.2020.100149","article-title":"An enriched environment prevents cognitive impairment in an Alzheimer\u2019s disease model by enhancing the secretion of exosomal microRNA-146a from the choroid plexus","volume":"9","author":"Nakano","year":"2020","journal-title":"Brain Behav Immun Health"},{"key":"10.3233\/JAD-240212_ref202","doi-asserted-by":"crossref","first-page":"7967","DOI":"10.1038\/ncomms8967","article-title":"Breaking immune tolerance by targeting Foxp3(+) regulatory T cells mitigates Alzheimer\u2019s disease pathology","volume":"6","author":"Baruch","year":"2015","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-240212_ref203","doi-asserted-by":"crossref","first-page":"e111515","DOI":"10.15252\/embj.2022111515","article-title":"Gut microbiota regulates blood-cerebrospinal fluid barrier function and A\u03b2 pathology","volume":"42","author":"Xie","year":"2023","journal-title":"EMBO J"},{"key":"10.3233\/JAD-240212_ref204","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.neurobiolaging.2013.07.019","article-title":"Klotho upregulation contributes to the neuroprotection of ligustilide in an Alzheimer\u2019s disease mouse model","volume":"35","author":"Kuang","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref205","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jnutbio.2017.10.014","article-title":"Lycopene mitigates \u03b2-amyloid induced inflammatory response and inhibits NF-\u03baB signaling at the choroid plexus in early stages of Alzheimer\u2019s disease rats","volume":"53","author":"Liu","year":"2018","journal-title":"J Nutr Biochem"},{"key":"10.3233\/JAD-240212_ref206","doi-asserted-by":"crossref","first-page":"108558","DOI":"10.1016\/j.jnutbio.2020.108558","article-title":"A combination of lycopene and human amniotic epithelial cells can ameliorate cognitive deficits and suppress neuroinflammatory signaling by choroid plexus in Alzheimer\u2019s disease rat","volume":"88","author":"Xu","year":"2021","journal-title":"J Nutr Biochem"},{"key":"10.3233\/JAD-240212_ref207","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.3389\/fimmu.2020.01781","article-title":"Administration of amyloid precursor protein gene deleted mouse ESC-derived thymic epithelial progenitors attenuates Alzheimer\u2019s pathology","volume":"11","author":"Zhao","year":"2020","journal-title":"Front Immunol"},{"key":"10.3233\/JAD-240212_ref208","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1073\/pnas.0712197105","article-title":"Transthyretin protects Alzheimer\u2019s mice from the behavioral and biochemical effects of Abeta toxicity","volume":"105","author":"Buxbaum","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref209","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15280\/jlm.2015.5.1.1","article-title":"Biological role of anti-aging protein Klotho","volume":"5","author":"Kim","year":"2015","journal-title":"J Lifestyle Med"},{"key":"10.3233\/JAD-240212_ref210","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.neurobiolaging.2006.03.015","article-title":"Transthyretin and Alzheimer\u2019s disease: Where in the brain?","volume":"28,","author":"Sousa","year":"2007","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref211","doi-asserted-by":"crossref","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","article-title":"A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2","volume":"4","author":"Iliff","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-240212_ref212","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrneurol.2015.119","article-title":"Clearance systems in the brain-implications for Alzheimer disease","volume":"11","author":"Tarasoff-Conway","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-240212_ref213","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s10571-015-0273-8","article-title":"Lymphatic clearance of the brain: Perivascular, paravascular and significance for neurodegenerative diseases","volume":"36","author":"Bakker","year":"2016","journal-title":"Cell Mol Neurobiol"},{"key":"10.3233\/JAD-240212_ref214","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3389\/fnana.2017.00101","article-title":"The paravascular pathway for brain waste clearance: Current understanding, significance and controversy","volume":"11","author":"Bacyinski","year":"2017","journal-title":"Front Neuroanat"},{"key":"10.3233\/JAD-240212_ref215","doi-asserted-by":"crossref","first-page":"e0139574","DOI":"10.1371\/journal.pone.0139574","article-title":"Modeling the role of the glymphatic pathway and cerebral blood vessel properties in Alzheimer\u2019s disease pathogenesis","volume":"10","author":"Kyrtsos","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-240212_ref216","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fnagi.2015.00115","article-title":"Impaired A\u03b2 clearance: A potential link between atherosclerosis and Alzheimer\u2019s disease","volume":"7","author":"Gupta","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-240212_ref217","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","article-title":"The glymphatic system in central nervous system health and disease: Past, present, and future","volume":"13","author":"Plog","year":"2018","journal-title":"Annu Rev Pathol"},{"key":"10.3233\/JAD-240212_ref218","first-page":"238","article-title":"How does the brain remove its waste metabolites from within?","volume":"11","author":"Cheng","year":"2019","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.3233\/JAD-240212_ref219","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.molmed.2019.11.008","article-title":"Glymphatic system impairment in Alzheimer\u2019s disease and idiopathic normal pressure hydrocephalus","volume":"26","author":"Reeves","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.3233\/JAD-240212_ref220","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","article-title":"The glymphatic system: A beginner\u2019s guide","volume":"40","author":"Jessen","year":"2015","journal-title":"Neurochem Res"},{"key":"10.3233\/JAD-240212_ref221","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000490349","article-title":"The glymphatic system and waste clearance with brain aging: A review","volume":"65","author":"Benveniste","year":"2019","journal-title":"Gerontology"},{"key":"10.3233\/JAD-240212_ref222","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","article-title":"The role of brain barriers in fluid movement in the CNS: Is there a \u2018glymphatic\u2019 system?","volume":"135","author":"Abbott","year":"2018","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref223","doi-asserted-by":"crossref","first-page":"4720","DOI":"10.1007\/s12035-020-02044-8","article-title":"Inhibition of aquaporin 4 decreases amyloid A\u03b240 drainage around cerebral vessels","volume":"57","author":"Rosu","year":"2020","journal-title":"Mol Neurobiol"},{"key":"10.3233\/JAD-240212_ref224","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/glia.20990","article-title":"The perivascular astroglial sheath provides a complete covering of the brain microvessels: An electron microscopic 3D reconstruction","volume":"58","author":"Mathiisen","year":"2010","journal-title":"Glia"},{"key":"10.3233\/JAD-240212_ref225","doi-asserted-by":"crossref","first-page":"e40070","DOI":"10.7554\/eLife.40070","article-title":"Aquaporin-4-dependent glymphatic solute transport in the rodent brain","volume":"7","author":"Mestre","year":"2018","journal-title":"Elife"},{"key":"10.3233\/JAD-240212_ref226","doi-asserted-by":"crossref","first-page":"90","DOI":"10.3390\/cells8020090","article-title":"Aquaporin-4 water channel in the brain and its implication for health and disease","volume":"8","author":"Mader","year":"2019","journal-title":"Cells"},{"key":"10.3233\/JAD-240212_ref227","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jamaneurol.2016.4370","article-title":"Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains","volume":"74","author":"Zeppenfeld","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-240212_ref228","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(85)91383-6","article-title":"Evidence for a \u2018paravascular\u2019 fluid circulation in the mammalian central nervous system, provided by the rapid distribution of tracer protein throughout the brain from the subarachnoid space","volume":"326","author":"Rennels","year":"1985","journal-title":"Brain Res"},{"key":"10.3233\/JAD-240212_ref229","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1046\/j.1471-4159.1996.67020880.x","article-title":"Fate of cerebrospinal fluid-borne amyloid beta-peptide: Rapid clearance into blood and appreciable accumulation by cerebral arteries","volume":"67","author":"Ghersi-Egea","year":"1996","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref230","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/j.1471-4159.2011.07311.x","article-title":"Amyloid-\u03b2 peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier","volume":"118","author":"Fujiyoshi","year":"2011","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref231","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature14432","article-title":"Structural and functional features of central nervous system lymphatic vessels","volume":"523","author":"Louveau","year":"2015","journal-title":"Nature"},{"key":"10.3233\/JAD-240212_ref232","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0014-4886(74)90099-5","article-title":"Bulk flow of interstitial fluid after intracranial injection of blue dextran 2000","volume":"45","author":"Cserr","year":"1974","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-240212_ref233","first-page":"F319","article-title":"Efflux of radiolabeled polyethylene glycols and albumin from rat brain","volume":"240","author":"Cserr","year":"1981","journal-title":"Am J Physiol"},{"key":"10.3233\/JAD-240212_ref234","first-page":"F835","article-title":"Drainage of interstitial fluid from different regions of rat brain","volume":"246","author":"Szentistvanyi","year":"1984","journal-title":"Am J Physiol"},{"key":"10.3233\/JAD-240212_ref235","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1085\/jgp.201611684","article-title":"Spatial model of convective solute transport in brain extracellular space does not support a \u201cglymphatic\u201d mechanism","volume":"148","author":"Jin","year":"2016","journal-title":"J Gen Physiol"},{"key":"10.3233\/JAD-240212_ref236","doi-asserted-by":"crossref","first-page":"e27679","DOI":"10.7554\/eLife.27679","article-title":"Test of the \u2018glymphatic\u2019 hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma","volume":"6","author":"Smith","year":"2017","journal-title":"Elife"},{"key":"10.3233\/JAD-240212_ref237","doi-asserted-by":"crossref","first-page":"9894","DOI":"10.1073\/pnas.1706942114","article-title":"Interstitial solute transport in 3D reconstructed neuropil occurs by diffusion rather than bulk flow","volume":"114","author":"Holter","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref238","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease - one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-240212_ref239","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1126\/science.1241224","article-title":"Sleep drives metabolite clearance from the adult brain","volume":"342","author":"Xie","year":"2013","journal-title":"Science"},{"key":"10.3233\/JAD-240212_ref240","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41398-018-0094-x","article-title":"Genetic variation in Aquaporin-4 moderates the relationship between sleep and brain A\u03b2-amyloid burden","volume":"8","author":"Rainey-Smith","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.3233\/JAD-240212_ref241","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/ana.24271","article-title":"Impairment of paravascular clearance pathways in the aging brain","volume":"76","author":"Kress","year":"2014","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-240212_ref242","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nbd.2016.05.015","article-title":"Suppression of glymphatic fluid transport in a mouse model of Alzheimer\u2019s disease","volume":"93","author":"Peng","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-240212_ref243","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13024-015-0056-1","article-title":"Deletion of aquaporin-4 in APP\/PS1 mice exacerbates brain A\u03b2 accumulation and memory deficits","volume":"10","author":"Xu","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240212_ref244","doi-asserted-by":"crossref","first-page":"711","DOI":"10.3233\/JAD-2011-110725","article-title":"Loss of astrocyte polarization in the tg-ArcSwe mouse model of Alzheimer\u2019s disease","volume":"27","author":"Yang","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref245","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/bpa.12656","article-title":"Deep cervical lymph node ligation aggravates AD-like pathology of APP\/PS1 mice","volume":"29","author":"Wang","year":"2019","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-240212_ref246","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41586-018-0368-8","article-title":"Functional aspects of meningeal lymphatics in ageing and Alzheimer\u2019s disease","volume":"560","author":"Da Mesquita","year":"2018","journal-title":"Nature"},{"key":"10.3233\/JAD-240212_ref247","doi-asserted-by":"crossref","first-page":"490","DOI":"10.3389\/fneur.2019.00490","article-title":"Development of a multicomponent intervention to prevent Alzheimer\u2019s disease","volume":"10","author":"Saito","year":"2019","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-240212_ref248","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.neuron.2019.10.033","article-title":"Vasomotion as a driving force for paravascular clearance in the awake mouse brain","volume":"105","author":"van Veluw","year":"2020","journal-title":"Neuron"},{"key":"10.3233\/JAD-240212_ref249","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1161\/STROKEAHA.114.006617","article-title":"Impaired glymphatic perfusion after strokes revealed by contrast-enhanced MRI: A new target for fibrinolysis?","volume":"45","author":"Gaberel","year":"2014","journal-title":"Stroke"},{"key":"10.3233\/JAD-240212_ref250","doi-asserted-by":"crossref","first-page":"16180","DOI":"10.1523\/JNEUROSCI.3020-14.2014","article-title":"Impairment of glymphatic pathway function promotes tau pathology after traumatic brain injury","volume":"34","author":"Iliff","year":"2014","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref251","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1523\/JNEUROSCI.2112-16.2017","article-title":"Focal solute trapping and global glymphatic pathway impairment in a murine model of multiple microinfarcts","volume":"37","author":"Wang","year":"2017","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref252","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1093\/brain\/awx191","article-title":"Glymphatic MRI in idiopathic normal pressure hydrocephalus","volume":"140","author":"Ringstad","year":"2017","journal-title":"Brain"},{"key":"10.3233\/JAD-240212_ref253","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1080\/00207454.2021.1946056","article-title":"Angiotensin II type 1 receptor deficiency protects against the impairment of blood-brain barrier in a mouse model of traumatic brain injury","volume":"133","author":"Yang","year":"2023","journal-title":"Int J Neurosci"},{"key":"10.3233\/JAD-240212_ref254","doi-asserted-by":"crossref","first-page":"494","DOI":"10.3390\/nu12020494","article-title":"5-caffeoylquinic acid ameliorates cognitive decline and reduces A\u03b2 deposition by modulating A\u03b2 clearance pathways in APP\/PS2 transgenic mice","volume":"12","author":"Ishida","year":"2020","journal-title":"Nutrients"},{"key":"10.3233\/JAD-240212_ref255","doi-asserted-by":"crossref","first-page":"9960304","DOI":"10.1155\/2021\/9960304","article-title":"Electroacupuncture improves clearance of amyloid-\u03b2 through the glymphatic system in the SAMP8 mouse model of Alzheimer\u2019s disease","volume":"2021","author":"Liang","year":"2021","journal-title":"Neural Plast"},{"key":"10.3233\/JAD-240212_ref256","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fnmol.2017.00144","article-title":"Voluntary exercise promotes glymphatic clearance of amyloid beta and reduces the activation of astrocytes and microglia in aged mice","volume":"10","author":"He","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-240212_ref257","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.4103\/1673-5374.335169","article-title":"Aquaporin 4 deficiency eliminates the beneficial effects of voluntary exercise in a mouse model of Alzheimer\u2019s disease","volume":"17","author":"Liu","year":"2022","journal-title":"Neural Regen Res"},{"key":"10.3233\/JAD-240212_ref258","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2174\/1567205015666180411092551","article-title":"Melatonin treatment enhances A\u03b2 lymphatic clearance in a transgenic mouse model of amyloidosis","volume":"15","author":"Pappolla","year":"2018","journal-title":"Curr Alzheimer Res"},{"key":"10.3233\/JAD-240212_ref259","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1523\/JNEUROSCI.0340-10.2010","article-title":"L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer\u2019s disease","volume":"30","author":"Peng","year":"2010","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref260","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/s12031-020-01752-z","article-title":"L-3-n-butylphthalide effectively improves the glymphatic clearance and reduce amyloid-\u03b2 deposition in Alzheimer\u2019s transgenic mice","volume":"71","author":"Zhang","year":"2021","journal-title":"J Mol Neurosci"},{"key":"10.3233\/JAD-240212_ref261","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1096\/fj.201600896","article-title":"Omega-3 polyunsaturated fatty acids promote amyloid-\u03b2 clearance from the brain through mediating the function of the glymphatic system","volume":"31","author":"Ren","year":"2017","journal-title":"FASEB J"},{"key":"10.3233\/JAD-240212_ref262","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.3390\/ijms23062975","article-title":"Photobiomodulation therapy and the glymphatic system: Promising applications for augmenting the brain lymphatic drainage system","volume":"23","author":"Salehpour","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref263","doi-asserted-by":"crossref","first-page":"2140524","DOI":"10.1155\/2022\/2140524","article-title":"Continuous theta-burst stimulation promotes paravascular CSF-interstitial fluid exchange through regulation of aquaporin-4 polarization in APP\/PS1 mice","volume":"2022","author":"Wu","year":"2022","journal-title":"Mediators Inflamm"},{"key":"10.3233\/JAD-240212_ref264","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/jcbfm.2013.30","article-title":"\u2018Hit & Run\u2019 model of closed-skull traumatic brain injury (TBI) reveals complex patterns of post-traumatic AQP4 dysregulation","volume":"33","author":"Ren","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.3233\/JAD-240212_ref265","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000494889","article-title":"Neuroendocrine-metabolic dysfunction and sleep disturbances in neurodegenerative disorders: Focus on Alzheimer\u2019s disease and melatonin","volume":"108","author":"Spinedi","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.3233\/JAD-240212_ref266","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1080\/01616412.2017.1315864","article-title":"A review of sleep disorders and melatonin","volume":"39","author":"Xie","year":"2017","journal-title":"Neurol Res"},{"key":"10.3233\/JAD-240212_ref267","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.smrv.2014.03.007","article-title":"Sleep and Alzheimer\u2019s disease","volume":"19","author":"Peter-Derex","year":"2015","journal-title":"Sleep Med Rev"},{"key":"10.3233\/JAD-240212_ref268","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-079X.2003.00065.x","article-title":"Early neuropathological Alzheimer\u2019s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels","volume":"35","author":"Zhou","year":"2003","journal-title":"J Pineal Res"},{"key":"10.3233\/JAD-240212_ref269","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s13024-015-0027-6","article-title":"Prophylactic melatonin significantly reduces Alzheimer\u2019s neuropathology and associated cognitive deficits independent of antioxidant pathways in A\u03b2PP(swe)\/PS1 mice","volume":"10","author":"O\u2019Neal-Moffitt","year":"2015","journal-title":"Mol Neurodegener"},{"key":"10.3233\/JAD-240212_ref270","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2990.2007.00926.x","article-title":"Solutes, but not cells, drain from the brain parenchyma along basement membranes of capillaries and arteries: Significance for cerebral amyloid angiopathy and neuroimmunology","volume":"34","author":"Carare","year":"2008","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-240212_ref271","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-008-0457-0","article-title":"Lymphatic drainage of the brain and the pathophysiology of neurological disease","volume":"117","author":"Weller","year":"2009","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref272","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/bpa.12159","article-title":"Failure of perivascular drainage of \u03b2-amyloid in cerebral amyloid angiopathy","volume":"24","author":"Hawkes","year":"2014","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-240212_ref273","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.20142290","article-title":"A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules","volume":"212","author":"Aspelund","year":"2015","journal-title":"J Exp Med"},{"key":"10.3233\/JAD-240212_ref274","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00401-011-0801-7","article-title":"Perivascular drainage of solutes is impaired in the ageing mouse brain and in the presence of cerebral amyloid angiopathy","volume":"121","author":"Hawkes","year":"2011","journal-title":"Acta Neuropathol"},{"key":"10.3233\/JAD-240212_ref275","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/acel.12045","article-title":"Regional differences in the morphological and functional effects of aging on cerebral basement membranes and perivascular drainage of amyloid-\u03b2 from the mouse brain","volume":"12","author":"Hawkes","year":"2013","journal-title":"Aging Cell"},{"key":"10.3233\/JAD-240212_ref276","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jtbi.2005.07.005","article-title":"Mechanisms to explain the reverse perivascular transport of solutes out of the brain","volume":"238","author":"Schley","year":"2006","journal-title":"J Theor Biol"},{"key":"10.3233\/JAD-240212_ref277","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3233\/JAD-142976","article-title":"Is vasomotion in cerebral arteries impaired in Alzheimer\u2019s disease?","volume":"46","author":"Di Marco","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref278","doi-asserted-by":"crossref","first-page":"18","DOI":"10.3389\/fnagi.2016.00018","article-title":"A simulation model of periarterial clearance of amyloid-\u03b2 from the brain","volume":"8","author":"Diem","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-240212_ref279","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fnagi.2014.00251","article-title":"The cerebrovascular basement membrane: Role in the clearance of \u03b2-amyloid and cerebral amyloid angiopathy","volume":"6","author":"Morris","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-240212_ref280","first-page":"249","article-title":"Beta amyloid is focally deposited within the outer basement membrane in the amyloid angiopathy of Alzheimer\u2019s disease. An immunoelectron microscopic study","volume":"141","author":"Yamaguchi","year":"1992","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-240212_ref281","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0002-9440(10)65616-7","article-title":"Cerebral amyloid angiopathy: Amyloid beta accumulates in putative interstitial fluid drainage pathways in Alzheimer\u2019s disease","volume":"153","author":"Weller","year":"1998","journal-title":"Am J Pathol"},{"key":"10.3233\/JAD-240212_ref282","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1046\/j.1365-2990.2003.00424.x","article-title":"Capillary and arterial cerebral amyloid angiopathy in Alzheimer\u2019s disease: Defining the perivascular route for the elimination of amyloid beta from the human brain","volume":"29","author":"Preston","year":"2003","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-240212_ref283","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/BF00314080","article-title":"Cerebral amyloid angiopathy in the aged","volume":"234","author":"Yamada","year":"1987","journal-title":"J Neurol"},{"key":"10.3233\/JAD-240212_ref284","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/B978-0-12-385883-2.00006-0","article-title":"Cerebral amyloid angiopathy","volume":"107","author":"Yamada","year":"2012","journal-title":"Prog Mol Biol Transl Sci"},{"key":"10.3233\/JAD-240212_ref285","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1161\/01.STR.0000143224.36527.44","article-title":"Amyloid angiopathy-related vascular cognitive impairment","volume":"35","author":"Greenberg","year":"2004","journal-title":"Stroke"},{"key":"10.3233\/JAD-240212_ref286","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1002\/ana.22516","article-title":"Cerebral amyloid angiopathy in the elderly","volume":"70","author":"Viswanathan","year":"2011","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-240212_ref287","first-page":"564","article-title":"Amyloid angiopathy in Alzheimer\u2019s disease","volume":"14","author":"Bergeron","year":"1987","journal-title":"Can J Neurol Sci"},{"key":"10.3233\/JAD-240212_ref288","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1212\/WNL.46.6.1592","article-title":"Cerebral amyloid angiopathy in the brains of patients with Alzheimer\u2019s disease: The CERAD experience, Part XV","volume":"46","author":"Ellis","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref289","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s007020200068","article-title":"Alzheimer disease and cerebrovascular pathology: An update","volume":"109","author":"Jellinger","year":"2002","journal-title":"J Neural Transm (Vienna)"},{"key":"10.3233\/JAD-240212_ref290","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1016\/j.neurobiolaging.2015.06.028","article-title":"Cerebral amyloid angiopathy and its co-occurrence with Alzheimer\u2019s disease and other cerebrovascular neuropathologic changes","volume":"36","author":"Brenowitz","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-240212_ref291","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","article-title":"Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons","volume":"85","author":"Boyle","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref292","doi-asserted-by":"crossref","first-page":"e41636","DOI":"10.1371\/journal.pone.0041636","article-title":"Disruption of arterial perivascular drainage of amyloid-\u03b2 from the brains of mice expressing the human APOE \u025b4 allele","volume":"7","author":"Hawkes","year":"2012","journal-title":"PLoS One"},{"key":"10.3233\/JAD-240212_ref293","doi-asserted-by":"crossref","first-page":"E4371","DOI":"10.3390\/ijms21124371","article-title":"ApoE4 astrocytes secrete basement membranes rich in fibronectin and poor in laminin compared to ApoE3 astrocytes","volume":"21","author":"Keable","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref294","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1212\/WNL.47.1.190","article-title":"The apolipoprotein E epsilon 4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer\u2019s disease and Lewy body variant","volume":"47","author":"Olichney","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref295","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0014-4886(03)00315-7","article-title":"Immunohistochemical study of distribution of apolipoproteins E and D in human cerebral beta amyloid deposits","volume":"184","author":"Navarro","year":"2003","journal-title":"Exp Neurol"},{"key":"10.3233\/JAD-240212_ref296","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/NEN.0b013e3181836a71","article-title":"Cerebral small vessel disease-induced apolipoprotein E leakage is associated with Alzheimer disease and the accumulation of amyloid beta-protein in perivascular astrocytes","volume":"67","author":"Utter","year":"2008","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-240212_ref297","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1016\/j.jacc.2019.07.081","article-title":"Long-term dabigatran treatment delays Alzheimer\u2019s disease pathogenesis in the TgCRND8 Mouse Model","volume":"74","author":"Cortes-Canteli","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.3233\/JAD-240212_ref298","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/nan.12556","article-title":"Knockout of apolipoprotein A-I decreases parenchymal and vascular \u03b2-amyloid pathology in the Tg2576 mouse model of Alzheimer\u2019s disease","volume":"45","author":"Contu","year":"2019","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-240212_ref299","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1073\/pnas.0805453106","article-title":"Selective targeting of perivascular macrophages for clearance of beta-amyloid in cerebral amyloid angiopathy","volume":"106","author":"Hawkes","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref300","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/acn3.79","article-title":"Phosphodiesterase III inhibitor promotes drainage of cerebrovascular \u03b2-amyloid","volume":"1","author":"Maki","year":"2014","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-240212_ref301","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.bbadis.2015.08.025","article-title":"Quantification of molecular interactions between ApoE, amyloid-beta (A\u03b2) and laminin: Relevance to accumulation of A\u03b2 in Alzheimer\u2019s disease","volume":"1862","author":"Zekonyte","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.3233\/JAD-240212_ref302","doi-asserted-by":"crossref","first-page":"1107436","DOI":"10.3389\/fnins.2023.1107436","article-title":"Ergothioneine, a dietary antioxidant improves amyloid beta clearance in the neuroretina of a mouse model of Alzheimer\u2019s disease","volume":"17","author":"Wijesinghe","year":"2023","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-240212_ref303","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s40478-020-01108-z","article-title":"Loss of cholinergic innervation differentially affects eNOS-mediated blood flow, drainage of A\u03b2 and cerebral amyloid angiopathy in the cortex and hippocampus of adult mice","volume":"9","author":"Nizari","year":"2021","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-240212_ref304","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3233\/JAD-132417","article-title":"Impaired hippocampal neurogenesis and its enhancement with ghrelin in 5XFAD mice","volume":"41","author":"Moon","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref305","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.3390\/ijms19061800","article-title":"MK-0677, a ghrelin agonist, alleviates amyloid beta-related pathology in 5XFAD mice, an animal model of Alzheimer\u2019s disease","volume":"19","author":"Jeong","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref306","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3233\/JAD-190779","article-title":"MK0677, a ghrelin mimetic, improves neurogenesis but fails to prevent hippocampal lesions in a mouse model of Alzheimer\u2019s disease pathology","volume":"72","author":"Tian","year":"2019","journal-title":". J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref307","first-page":"100171","article-title":"Targeting lysyl-oxidase (LOX) may facilitate intramural periarterial drainage for the treatment of Alzheimer\u2019s disease","volume":"5","author":"Kelly","year":"2023","journal-title":"Cereb Circ Cogn Behav"},{"key":"10.3233\/JAD-240212_ref308","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/brain\/awv313","article-title":"Passive immunotherapy targeting amyloid-\u03b2 reduces cerebral amyloid angiopathy and improves vascular reactivity","volume":"139","author":"Bales","year":"2016","journal-title":"Brain"},{"key":"10.3233\/JAD-240212_ref309","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40478-017-0429-5","article-title":"Taxifolin inhibits amyloid-\u03b2 oligomer formation and fully restores vascular integrity and memory in cerebral amyloid angiopathy","volume":"5","author":"Saito","year":"2017","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-240212_ref310","doi-asserted-by":"crossref","first-page":"643357","DOI":"10.3389\/fphar.2021.643357","article-title":"Taxifolin: A potential therapeutic agent for cerebral amyloid angiopathy","volume":"12","author":"Saito","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-240212_ref311","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.3233\/JAD-200610","article-title":"Anticoagulants for treatment of Alzheimer\u2019s disease","volume":"77","author":"Grossmann","year":"2020","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref312","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1002\/1873-3468.13950","article-title":"Apolipoprotein A-I in mouse cerebrospinal fluid derives from the liver and intestine via plasma high-density lipoproteins assembled by ABCA1 and LCAT","volume":"595","author":"Tsujita","year":"2021","journal-title":"FEBS Lett"},{"key":"10.3233\/JAD-240212_ref313","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/FJC.0b013e3182a3718f","article-title":"Rho kinases in cardiovascular physiology and pathophysiology: The effect of fasudil","volume":"62","author":"Shi","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.3233\/JAD-240212_ref314","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.trci.2017.05.003","article-title":"Ponezumab in mild-to-moderate Alzheimer\u2019s disease: Randomized phase II PET-PIB study","volume":"3","author":"Landen","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-240212_ref315","doi-asserted-by":"crossref","first-page":"8823","DOI":"10.3390\/molecules27248823","article-title":"BACE1 inhibitors for Alzheimer\u2019s disease: The past, present and any future?","volume":"27","author":"Bazzari","year":"2022","journal-title":"Molecules"},{"key":"10.3233\/JAD-240212_ref316","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1146\/annurev-pharmtox-010814-124309","article-title":"Learning by failing: Ideas and concepts to tackle \u03b3-secretases in Alzheimer\u2019s disease and beyond","volume":"55","author":"De Strooper","year":"2015","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.3233\/JAD-240212_ref317","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.nbd.2003.09.015","article-title":"Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration","volume":"15","author":"Wilcock","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-240212_ref318","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1523\/JNEUROSCI.5572-08.2009","article-title":"Microglia mediate the clearance of soluble Abeta through fluid phase macropinocytosis","volume":"29","author":"Mandrekar","year":"2009","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref319","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00018-017-2463-7","article-title":"Clearance of cerebral A\u03b2 in Alzheimer\u2019s disease: Reassessing the role of microglia and monocytes","volume":"74","author":"Zuroff","year":"2017","journal-title":"Cell Mol Life Sci"},{"key":"10.3233\/JAD-240212_ref320","volume-title":"Immunobiology. The Immune System in Health and Disease","author":"Janeway","year":"1996"},{"key":"10.3233\/JAD-240212_ref321","first-page":"983640","article-title":"Microglia, Alzheimer\u2019s disease, and complement","volume":"2012","author":"Crehan","year":"2012","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref322","doi-asserted-by":"crossref","first-page":"4109","DOI":"10.1073\/pnas.94.8.4109","article-title":"Disaggregation of Alzheimer beta-amyloid by site-directed mAb","volume":"94","author":"Solomon","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref323","doi-asserted-by":"crossref","first-page":"8850","DOI":"10.1073\/pnas.151261398","article-title":"Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer\u2019s disease","volume":"98","author":"DeMattos","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 2","key":"10.3233\/JAD-240212_ref324","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/brain\/awt308","article-title":"Sustained peripheral depletion of amyloid-\u03b2 with a novel form of neprilysin does not affect central levels of amyloid-\u03b2","volume":"137","author":"Henderson","year":"2014","journal-title":"Brain"},{"key":"10.3233\/JAD-240212_ref325","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/jnc.12937","article-title":"Revisiting the peripheral sink hypothesis: Inhibiting BACE1 activity in the periphery does not alter \u03b2-amyloid levels in the CNS","volume":"132","author":"Georgievska","year":"2015","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-240212_ref326","doi-asserted-by":"crossref","first-page":"105010","DOI":"10.1016\/j.nbd.2020.105010","article-title":"Passive immunotherapies targeting A\u03b2 and tau in Alzheimer\u2019s disease","volume":"144","author":"Plotkin","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-240212_ref327","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing \u03b2-amyloid plaques in Alzheimer\u2019s disease mice","volume":"76","author":"Demattos","year":"2012","journal-title":"Neuron"},{"key":"10.3233\/JAD-240212_ref328","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s13195-022-01124-2","article-title":"Lecanemab in patients with early Alzheimer\u2019s disease: Detailed results on biomarker, cognitive, and clinical effects from the randomized and open-label extension of the phase 2 proof-of-concept study","volume":"14","author":"McDade","year":"2022","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-240212_ref329","first-page":"e12503","article-title":"Validation of 3- and 5-point severity scales to assess ARIA-E","volume":"15","author":"Bracoud","year":"2023","journal-title":"(Amst)"},{"key":"10.3233\/JAD-240212_ref330","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2214\/AJR.22.28461","article-title":"Amyloid-related imaging abnormalities: An update","volume":"220","author":"Roytman","year":"2023","journal-title":"AJR Am J Roentgenol"},{"key":"10.3233\/JAD-240212_ref331","doi-asserted-by":"crossref","first-page":"1326784","DOI":"10.3389\/fnins.2024.1326784","article-title":"Risk factors in developing amyloid related imaging abnormalities (ARIA) and clinical implications","volume":"18","author":"Doran","year":"2024","journal-title":"Front Neurosci"},{"key":"10.3233\/JAD-240212_ref332","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): Radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.3233\/JAD-240212_ref333","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2011.05.2351","article-title":"Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer\u2019s Association Research Roundtable Workgroup","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240212_ref334","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta","volume":"25","author":"Racke","year":"2005","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref335","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1523\/JNEUROSCI.4742-11.2012","article-title":"An effector-reduced anti-\u03b2-amyloid (A\u03b2) antibody with unique a\u03b2 binding properties promotes neuroprotection and glial engulfment of A\u03b2","volume":"32","author":"Adolfsson","year":"2012","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-240212_ref336","first-page":"241","article-title":"Amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with bapineuzumab: A retrospective analysis","volume":"11","author":"Sperling","year":"2012","journal-title":"Neurol"},{"key":"10.3233\/JAD-240212_ref337","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1001\/archneur.65.6.790","article-title":"Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study","volume":"65","author":"Pettersen","year":"2008","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-240212_ref338","first-page":"211","article-title":"Detection and management of amyloid-related imaging abnormalities in patients with Alzheimer\u2019s disease treated with anti-amyloid beta therapy","volume":"9","author":"Barakos","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref339","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3389\/fonc.2019.00297","article-title":"Gene therapy leaves a vicious cycle","volume":"9","author":"Goswami","year":"2019","journal-title":"Front Oncol"},{"key":"10.3233\/JAD-240212_ref340","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/1535676019899502","article-title":"Viral vector systems for gene therapy: A comprehensive literature review of progress and biosafety challenges","volume":"25","author":"Ghosh","year":"2020","journal-title":"Applied Biosafety"},{"key":"10.3233\/JAD-240212_ref341","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3389\/fneur.2012.00133","article-title":"Cerebral microbleeds on magnetic resonance imaging and anticoagulant-associated intracerebral hemorrhage risk","volume":"3","author":"Charidimou","year":"2012","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-240212_ref342","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/alzrt263","article-title":"Cerebral microbleeds: Overview and implications in cognitive impairment","volume":"6","author":"Martinez-Ramirez","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-240212_ref343","doi-asserted-by":"crossref","first-page":"390","DOI":"10.21873\/cgp.20328","article-title":"Molecular genetics and targeted therapies for paediatric high-grade glioma","volume":"19","author":"Rallis","year":"2022","journal-title":"Cancer Genomics Proteomics"},{"key":"10.3233\/JAD-240212_ref344","doi-asserted-by":"crossref","first-page":"3184","DOI":"10.12659\/MSM.907569","article-title":"Efficacy, safety, and cost of therapy of the traditional chinese medicine, catalpol, in patients following surgical resection for locally advanced colon cancer","volume":"24","author":"Fei","year":"2018","journal-title":"Med Sci Monit"},{"key":"10.3233\/JAD-240212_ref345","first-page":"215","article-title":"The efficacy and use of anticonvulsants in mood disorders","volume":"21","author":"Dunn","year":"1998","journal-title":"Clin Neuropharmacol"},{"key":"10.3233\/JAD-240212_ref346","doi-asserted-by":"crossref","first-page":"e000473","DOI":"10.1136\/openhrt-2016-000473","article-title":"Amlodipine in hypertension: A first-line agent with efficacy for improving blood pressure and patient outcomes","volume":"3","author":"Fares","year":"2016","journal-title":"Open Heart"},{"key":"10.3233\/JAD-240212_ref347","first-page":"67","article-title":"New generations of dihydropyridines for treatment of hypertension","volume":"14","author":"Wang","year":"2017","journal-title":"J Geriatr Cardiol"},{"key":"10.3233\/JAD-240212_ref348","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1038\/mp.2016.86","article-title":"A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development","volume":"21","author":"Cipriani","year":"2016","journal-title":"Mol Psychiatry"},{"key":"10.3233\/JAD-240212_ref349","doi-asserted-by":"crossref","first-page":"e29564","DOI":"10.1002\/pbc.29564","article-title":"Comparison of the effects of calcium channel blockers plus iron chelation therapy versus chelation therapy only on iron overload in children and young adults with transfusion-dependent thalassemia: A randomized double-blind placebo-controlled trial","volume":"69","author":"Gupta","year":"2022","journal-title":"Pediatr Blood Cancer"},{"key":"10.3233\/JAD-240212_ref350","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/JCP.0000000000001274","article-title":"Adjunctive raloxifene and isradipine improve cognitive functioning in patients with schizophrenia: A pilot study","volume":"40","author":"Vahdani","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"10.3233\/JAD-240212_ref351","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.3390\/antiox11112120","article-title":"Vitamin D3 and ischemic stroke: A narrative review","volume":"11","author":"Laso\u0144","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.3233\/JAD-240212_ref352","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s40268-017-0210-z","article-title":"Pharmacokinetics of a new oral vitamin D receptor activator (2-methylene-19-Nor-(20S)-1\u03b1,25-dihydroxyvitamin D3) in patients with chronic kidney disease and secondary hyperparathyroidism on hemodialysis","volume":"17","author":"Pandey","year":"2017","journal-title":"Drugs R D"},{"key":"10.3233\/JAD-240212_ref353","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.exphem.2017.01.007","article-title":"Application of vitamin D and vitamin D analogs in acute myelogenous leukemia","volume":"50","author":"Cao","year":"2017","journal-title":"Exp Hematol"},{"key":"10.3233\/JAD-240212_ref354","doi-asserted-by":"crossref","first-page":"729","DOI":"10.3390\/ijms17050729","article-title":"The use of 1\u03b1,25-dihydroxyvitamin D3 as an anticancer agent","volume":"17","author":"Marcinkowska","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref355","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1358\/dot.2012.48.3.1745223","article-title":"Eldecalcitol for the treatment of osteoporosis","volume":"48","author":"Matsumoto","year":"2012","journal-title":"Drugs Today (Barc)"},{"key":"10.3233\/JAD-240212_ref356","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1139\/cjpp-2014-0419","article-title":"Vitamin D3 analogs for the treatment of osteoporosis","volume":"93","author":"Hagino","year":"2015","journal-title":"Can J Physiol Pharmacol"},{"key":"10.3233\/JAD-240212_ref357","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1440-1746.1999.01913.x","article-title":"Calcitriol for bone disease in patients with cirrhosis of the liver","volume":"14","author":"Shiomi","year":"1999","journal-title":"J Gastroenterol Hepatol"},{"key":"10.3233\/JAD-240212_ref358","doi-asserted-by":"crossref","first-page":"354","DOI":"10.3389\/fmed.2018.00354","article-title":"Recent advances in endothelial progenitor cells toward their use in clinical translation","volume":"5","author":"Keighron","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"10.3233\/JAD-240212_ref359","doi-asserted-by":"crossref","first-page":"1960804","DOI":"10.1155\/2017\/1960804","article-title":"The use of endothelial progenitor cells for the regeneration of musculoskeletal and neural tissues","volume":"2017","author":"Kamei","year":"2017","journal-title":"Stem Cells Int"},{"key":"10.3233\/JAD-240212_ref360","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3727\/096368912X658007","article-title":"Autologous G-CSF-mobilized peripheral blood CD34+cell therapy for diabetic patients with chronic nonhealing ulcer","volume":"23","author":"Tanaka","year":"2014","journal-title":"Cell Transplant"},{"key":"10.3233\/JAD-240212_ref361","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/stem.207","article-title":"Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: A phase I\/IIa, multicenter, single-blinded, dose-escalation clinical trial","volume":"27","author":"Kawamoto","year":"2009","journal-title":"Stem Cells"},{"key":"10.3233\/JAD-240212_ref362","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2005.02.148","article-title":"Physical exercise in cancer patients during and after medical treatment: A systematic review of randomized and controlled clinical trials","volume":"23","author":"Knols","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.3233\/JAD-240212_ref363","doi-asserted-by":"crossref","first-page":"101673","DOI":"10.1016\/j.arr.2022.101673","article-title":"Impact of exercise intervention-based changes on physical function biomarkers in older adults after hospital discharge: A systematic review with meta-analysis of randomized clinical trials","volume":"80","author":"Carneiro","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-240212_ref364","doi-asserted-by":"crossref","first-page":"5102","DOI":"10.3390\/nu14235102","article-title":"Extra-virgin olive oil enhances the blood-brain barrier function in mild cognitive impairment: A randomized controlled trial","volume":"14","author":"Kaddoumi","year":"2022","journal-title":"Nutrients"},{"key":"10.3233\/JAD-240212_ref365","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s40259-018-0325-y","article-title":"Lanadelumab for the prophylactic treatment of hereditary angioedema with C1 inhibitor deficiency: A review of preclinical and phase I studies","volume":"33","author":"Busse","year":"2019","journal-title":"BioDrugs"},{"key":"10.3233\/JAD-240212_ref366","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1016\/j.jaci.2021.10.038","article-title":"KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results","volume":"149","author":"Maetzel","year":"2022","journal-title":"J Allergy Clin Immunol"},{"key":"10.3233\/JAD-240212_ref367","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3727\/096368915X689622","article-title":"Clinical trials with mesenchymal stem cells: An update","volume":"25","author":"Squillaro","year":"2016","journal-title":"Cell Transplant"},{"key":"10.3233\/JAD-240212_ref368","first-page":"1021","article-title":"Andecaliximab [anti-matrix metalloproteinase-9] induction therapy for ulcerative colitis: A randomised, double-blind, placebo-controlled, phase 2\/3 study in patients with moderate to severe disease","volume":"12","author":"Sandborn","year":"2018","journal-title":"J Crohns Colitis"},{"key":"10.3233\/JAD-240212_ref369","doi-asserted-by":"crossref","first-page":"156-165.e5","DOI":"10.1016\/j.clinthera.2017.11.011","article-title":"Phase 1b study of the safety, pharmacokinetics, and disease-related outcomes of the matrix metalloproteinase-9 inhibitor andecaliximab in patients with rheumatoid arthritis","volume":"40","author":"Gossage","year":"2018","journal-title":"Clin Ther"},{"key":"10.3233\/JAD-240212_ref370","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1158\/1078-0432.CCR-17-2469","article-title":"Andecaliximab\/GS-5745 alone and combined with mFOLFOX6 in advanced gastric and gastroesophageal junction adenocarcinoma: Results from a phase I study","volume":"24","author":"Shah","year":"2018","journal-title":"Clin Cancer Res"},{"key":"10.3233\/JAD-240212_ref371","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.biopsych.2012.09.031","article-title":"Antidepressant effects of the muscarinic cholinergic receptor antagonist scopolamine: A review","volume":"73","author":"Drevets","year":"2013","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-240212_ref372","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jaapos.2007.10.014","article-title":"Two-year multicenter, randomized, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia","volume":"12","author":"Siatkowski","year":"2008","journal-title":"J AAPOS"},{"key":"10.3233\/JAD-240212_ref373","doi-asserted-by":"crossref","first-page":"771","DOI":"10.3201\/eid1705.101229","article-title":"Intravenous artesunate for severe malaria in travelers, Europe","volume":"17","author":"Zoller","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"10.3233\/JAD-240212_ref374","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1681\/ASN.2009121291","article-title":"Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease","volume":"21","author":"Hogan","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.3233\/JAD-240212_ref375","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin analogs in clinical practice: A review","volume":"21","author":"Gomes-Porras","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.3233\/JAD-240212_ref376","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJM199704243361704","article-title":"A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer\u2019s disease. The Alzheimer\u2019s Disease Cooperative Study","volume":"336","author":"Sano","year":"1997","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-240212_ref377","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1001\/jama.2013.282834","article-title":"Effect of vitamin E and memantine on functional decline in Alzheimer disease: The TEAM-AD VA cooperative randomized trial","volume":"311","author":"Dysken","year":"2014","journal-title":"JAMA"},{"key":"10.3233\/JAD-240212_ref378","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.biopha.2005.06.005","article-title":"Alpha-tocopherol: Roles in prevention and therapy of human disease","volume":"59","author":"Tucker","year":"2005","journal-title":"Biomed Pharmacother"},{"key":"10.3233\/JAD-240212_ref379","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3109\/09638288.2013.788218","article-title":"An enriched environment increases activity in stroke patients undergoing rehabilitation in a mixed rehabilitation unit: A pilot non-randomized controlled trial","volume":"36","author":"Janssen","year":"2014","journal-title":"Disabil Rehabil"},{"key":"10.3233\/JAD-240212_ref380","doi-asserted-by":"crossref","first-page":"417","DOI":"10.2340\/16501977-2081","article-title":"An enriched environmental programme during inpatient neuro-rehabilitation: A randomized controlled trial","volume":"48","author":"Khan","year":"2016","journal-title":"J Rehabil Med"},{"key":"10.3233\/JAD-240212_ref381","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1177\/0269215517705181","article-title":"Embedding an enriched environment in an acute stroke unit increases activity in people with stroke: A controlled before-after pilot study","volume":"31","author":"Rosbergen","year":"2017","journal-title":"Clin Rehabil"},{"key":"10.3233\/JAD-240212_ref382","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1182\/blood-2008-01-135319","article-title":"Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines","volume":"112","author":"Morse","year":"2008","journal-title":"Blood"},{"key":"10.3233\/JAD-240212_ref383","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s40425-016-0140-2","article-title":"Single dose denileukin diftitox does not enhance vaccine-induced T cell responses or effectively deplete Tregs in advanced melanoma: Immune monitoring and clinical results of a randomized phase II trial","volume":"4","author":"Luke","year":"2016","journal-title":"J Immunother Cancer"},{"key":"10.3233\/JAD-240212_ref384","doi-asserted-by":"crossref","first-page":"17945","DOI":"10.1073\/pnas.1316796110","article-title":"Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans","volume":"110","author":"Sugiyama","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-240212_ref385","doi-asserted-by":"crossref","first-page":"4327","DOI":"10.1158\/1078-0432.CCR-15-0357","article-title":"Phase Ia study of FoxP3+CD4 Treg depletion by infusion of a humanized anti-CCR4 antibody, KW-0761, in cancer patients","volume":"21","author":"Kurose","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.3233\/JAD-240212_ref386","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: A multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.3233\/JAD-240212_ref387","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","article-title":"Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"32","author":"Ogura","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.3233\/JAD-240212_ref388","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1253\/circj.71.1181","article-title":"A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: An initial report of the phase I-IIa study","volume":"71","author":"Marui","year":"2007","journal-title":"Circ J"},{"key":"10.3233\/JAD-240212_ref389","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/jor.20315","article-title":"Local application of recombinant human fibroblast growth factor-2 on bone repair: A dose-escalation prospective trial on patients with osteotomy","volume":"25","author":"Kawaguchi","year":"2007","journal-title":"J Orthop Res"},{"key":"10.3233\/JAD-240212_ref390","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s41232-016-0002-9","article-title":"Joint-preserving regenerative therapy for patients with early-stage osteonecrosis of the femoral head","volume":"36","author":"Kuroda","year":"2016","journal-title":"Inflamm Regen"},{"key":"10.3233\/JAD-240212_ref391","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/jbmr.146","article-title":"A local application of recombinant human fibroblast growth factor 2 for tibial shaft fractures: A randomized, placebo-controlled trial","volume":"25","author":"Kawaguchi","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.3233\/JAD-240212_ref392","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1600-051X.1989.tb02334.x","article-title":"A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration","volume":"16","author":"Lynch","year":"1989","journal-title":"J Clin Periodontol"},{"key":"10.3233\/JAD-240212_ref393","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1741-7015-8-76","article-title":"Topical insulin-like growth factor 1 treatment using gelatin hydrogels for glucocorticoid-resistant sudden sensorineural hearing loss: A prospective clinical trial","volume":"8","author":"Nakagawa","year":"2010","journal-title":"BMC Med"},{"key":"10.3233\/JAD-240212_ref394","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/S0015-0282(97)00397-X","article-title":"Does dong quai have estrogenic effects in postmenopausal women? A double-blind, placebo-controlled trial","volume":"68","author":"Hirata","year":"1997","journal-title":"Fertil Steril"},{"key":"10.3233\/JAD-240212_ref395","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/GME.0b013e318267f64e","article-title":"A randomized, double-blind, multiple-dose escalation study of a Chinese herbal medicine preparation (Dang Gui Buxue Tang) for moderate to severe menopausal symptoms and quality of life in postmenopausal women","volume":"20","author":"Wang","year":"2013","journal-title":"Menopause"},{"key":"10.3233\/JAD-240212_ref396","doi-asserted-by":"crossref","first-page":"102801","DOI":"10.1016\/j.ctim.2022.102801","article-title":"The effect of lycopene supplement from different sources on prostate specific antigen (PSA): A systematic review and meta-analysis of randomized controlled trials","volume":"64","author":"Sharifi-Zahabi","year":"2022","journal-title":"Complement Ther Med"},{"key":"10.3233\/JAD-240212_ref397","doi-asserted-by":"crossref","first-page":"e99070","DOI":"10.1371\/journal.pone.0099070","article-title":"Effects of oral lycopene supplementation on vascular function in patients with cardiovascular disease and healthy volunteers: A randomised controlled trial","volume":"9","author":"Gajendragadkar","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-240212_ref398","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1002\/jcb.26185","article-title":"Therapeutic potential of matrix metalloproteinase inhibition in breast cancer","volume":"118","author":"Radisky","year":"2017","journal-title":"J Cell Biochem"},{"key":"10.3233\/JAD-240212_ref399","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3390\/cells8090984","article-title":"The rebirth of matrix metalloproteinase inhibitors: Moving beyond the dogma","volume":"8","author":"Fields","year":"2019","journal-title":"Cells"},{"key":"10.3233\/JAD-240212_ref400","doi-asserted-by":"crossref","first-page":"6095","DOI":"10.1038\/s41467-022-33719-6","article-title":"Phase I trial of the TNF-\u03b1 inhibitor certolizumab plus chemotherapy in stage IV lung adenocarcinomas","volume":"13","author":"Paik","year":"2022","journal-title":"Nat Commun"},{"key":"10.3233\/JAD-240212_ref401","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1080\/13543784.2021.2010187","article-title":"Disease modification in ankylosing spondylitis with TNF inhibitors: Spotlight on early phase clinical trials","volume":"30","author":"Garcia-Montoya","year":"2021","journal-title":"Expert Opin Investig Drugs"},{"key":"10.3233\/JAD-240212_ref402","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/BOR.0b013e32835fc62e","article-title":"Newest clinical trial results with antitumor necrosis factor and nonantitumor necrosis factor biologics for rheumatoid arthritis","volume":"25","author":"Navarro-Mill\u00e1n","year":"2013","journal-title":"Curr Opin Rheumatol"},{"key":"10.3233\/JAD-240212_ref403","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1159\/000289205","article-title":"The first decade of biologic TNF antagonists in clinical practice: Lessons learned, unresolved issues and future directions","volume":"11","author":"Sfikakis","year":"2010","journal-title":"Curr Dir Autoimmun"},{"key":"10.3233\/JAD-240212_ref404","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00296-022-05136-x","article-title":"The second decade of anti-TNF-a therapy in clinical practice: New lessons and future directions in the COVID-19 era","volume":"42","author":"Evangelatos","year":"2022","journal-title":"Rheumatol Int"},{"key":"10.3233\/JAD-240212_ref405","doi-asserted-by":"crossref","first-page":"e004769","DOI":"10.1161\/CIRCHEARTFAILURE.117.004769","article-title":"TTR (transthyretin) stabilizers are associated with improved survival in patients with TTR cardiac amyloidosis","volume":"11","author":"Rosenblum","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.3233\/JAD-240212_ref406","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.3390\/jcm11082148","article-title":"Treatment of transthyretin amyloid cardiomyopathy: The current options, the future, and the challenges","volume":"11","author":"Tsch\u00f6pe","year":"2022","journal-title":"J Clin Med"},{"key":"10.3233\/JAD-240212_ref407","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00228-020-03081-x","article-title":"Safety and efficacy of tolcapone in Parkinson\u2019s disease: Systematic review","volume":"77","author":"Artusi","year":"2021","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3233\/JAD-240212_ref408","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: A randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA"},{"key":"10.3233\/JAD-240212_ref409","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12987-022-00330-2","article-title":"Experimental approaches for manipulating choroid plexus epithelial cells","volume":"19","author":"Jang","year":"2022","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-240212_ref410","doi-asserted-by":"crossref","first-page":"949231","DOI":"10.3389\/fnmol.2022.949231","article-title":"Choroid plexus epithelium and its role in neurological diseases","volume":"15","author":"Liu","year":"2022","journal-title":"Front Mol Neurosci"},{"key":"10.3233\/JAD-240212_ref411","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/1570159X13666141210215655","article-title":"Caffeine: Cognitive and physical performance enhancer or psychoactive drug?","volume":"13","author":"Cappelletti","year":"2015","journal-title":"Curr Neuropharmacol"},{"key":"10.3233\/JAD-240212_ref413","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.clnu.2016.11.013","article-title":"Mediation of coffee-induced improvements in human vascular function by chlorogenic acids and its metabolites: Two randomized, controlled, crossover intervention trials","volume":"36","author":"Mills","year":"2017","journal-title":"Clin Nutr"},{"key":"10.3233\/JAD-240212_ref414","doi-asserted-by":"crossref","first-page":"465","DOI":"10.20892\/j.issn.2095-3941.2022.0762","article-title":"Phase I study of chlorogenic acid injection for recurrent high-grade glioma with long-term follow-up","volume":"20","author":"Kang","year":"2023","journal-title":"Cancer Biol Med"},{"key":"10.3233\/JAD-240212_ref415","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3233\/JAD-201381","article-title":"Donepezil combined with DL-3-n-butylphthalide delays cognitive decline in patients with mild to moderate Alzheimer\u2019s disease: A multicenter, prospective cohort study","volume":"80","author":"Wang","year":"2021","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-240212_ref416","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jalz.2015.04.010","article-title":"The effects of DL-3-n-butylphthalide in patients with vascular cognitive impairment without dementia caused by subcortical ischemic small vessel disease: A multicentre, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Jia","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240212_ref417","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.3760\/cma.j.issn.0366-6999.20123240","article-title":"Ninety-day administration of dl-3-n-butylphthalide for acute ischemic stroke: A randomized, double-blind trial","volume":"126","author":"Cui","year":"2013","journal-title":"Chin Med J (Engl)"},{"key":"10.3233\/JAD-240212_ref418","doi-asserted-by":"crossref","first-page":"963118","DOI":"10.3389\/fphar.2022.963118","article-title":"DL-3-n-butylphthalide for acute ischemic stroke: An updated systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Wang","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-240212_ref419","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/CM9.0000000000002442","article-title":"A multicenter, randomized, double blind, placebo-controlled clinical trial of DL-3-n-butylphthalide in treatment of amyotrophic lateral sclerosis","volume":"136","author":"Liu","year":"2023","journal-title":"Chin Med J (Engl)"},{"key":"10.3233\/JAD-240212_ref420","doi-asserted-by":"crossref","first-page":"e16082","DOI":"10.1097\/MD.0000000000016082","article-title":"L-3-n-butylphthalide soft capsules in the treatment of Parkinson disease dementia: A systematic review and meta-analysis of randomized controlled trials","volume":"98","author":"Zhong","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.3233\/JAD-240212_ref421","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/gps.4571","article-title":"Meta-analysis of randomized, double-blind, placebo-controlled trials of melatonin in Alzheimer\u2019s disease","volume":"32","author":"Wang","year":"2017","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-240212_ref422","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1475-2891-13-106","article-title":"The effectiveness of melatonin for promoting healthy sleep: A rapid evidence assessment of the literature","volume":"13","author":"Costello","year":"2014","journal-title":"Nutr J"},{"key":"10.3233\/JAD-240212_ref423","doi-asserted-by":"crossref","first-page":"e40025","DOI":"10.2196\/40025","article-title":"Melatonin for neuropathic pain: Protocol for a double-blind, randomized controlled trial","volume":"11","author":"Gilron","year":"2022","journal-title":"JMIR Res Protoc"},{"key":"10.3233\/JAD-240212_ref424","doi-asserted-by":"crossref","first-page":"100763","DOI":"10.1016\/j.eclinm.2021.100763","article-title":"Adjuvant melatonin for the prevention of recurrence and mortality following lung cancer resection (AMPLCaRe): A randomized placebo controlled clinical trial","volume":"33","author":"Seely","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.3233\/JAD-240212_ref425","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/030089168707300508","article-title":"Clinical study of melatonin in untreatable advanced cancer patients","volume":"73","author":"Lissoni","year":"1987","journal-title":"Tumori"},{"key":"10.3233\/JAD-240212_ref426","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-079X.2005.00258.x","article-title":"Melatonin in the treatment of cancer: A systematic review of randomized controlled trials and meta-analysis","volume":"39","author":"Mills","year":"2005","journal-title":"J Pineal Res"},{"key":"10.3233\/JAD-240212_ref427","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1136\/jnnp-2016-313458","article-title":"Randomised clinical trial comparing melatonin 3\u200amg, amitriptyline 25\u200amg and placebo for migraine prevention","volume":"87","author":"Gon\u00e7alves","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-240212_ref428","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s11845-021-02758-1","article-title":"A pilot study on the melatonin treatment in patients with early septic shock: Results of a single-center randomized controlled trial","volume":"191","author":"Taher","year":"2022","journal-title":"Ir J Med Sci"},{"key":"10.3233\/JAD-240212_ref429","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.2174\/092986710791233689","article-title":"Clinical uses of melatonin: Evaluation of human trials","volume":"17","author":"S\u00e1nchez-Barcel\u00f3","year":"2010","journal-title":"Curr Med Chem"},{"key":"10.3233\/JAD-240212_ref430","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/gps.1857","article-title":"Omega-3 supplementation in mild to moderate Alzheimer\u2019s disease: Effects on neuropsychiatric symptoms","volume":"23","author":"Freund-Levi","year":"2008","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-240212_ref431","doi-asserted-by":"crossref","first-page":"y1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy in Alzheimer\u2019s disease and mild cognitive impairment: A preliminary randomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatr"},{"key":"10.3233\/JAD-240212_ref432","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2010.1510","article-title":"Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: A randomized trial","volume":"304","author":"Quinn","year":"2010","journal-title":"JAMA"},{"key":"10.3233\/JAD-240212_ref433","first-page":"CD009002","article-title":"Omega-3 fatty acids for the treatment of dementia","volume":"4","author":"Burckhardt","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-240212_ref434","doi-asserted-by":"crossref","first-page":"171","DOI":"10.14797\/mdcj-15-3-171","article-title":"Recent clinical trials shed new light on the cardiovascular benefits of omega-3 fatty acids","volume":"15","author":"Kris-Etherton","year":"2019","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.3233\/JAD-240212_ref435","doi-asserted-by":"crossref","first-page":"809311","DOI":"10.3389\/fnut.2022.809311","article-title":"Omega-3 fatty acid supplementation and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials","volume":"9","author":"Shen","year":"2022","journal-title":"Front Nutr"},{"key":"10.3233\/JAD-240212_ref436","doi-asserted-by":"crossref","first-page":"e14854","DOI":"10.1111\/ijcp.14854","article-title":"Omega-3 polyunsaturated fatty acids supplementation improve clinical symptoms in patients with Covid-19: A randomised clinical trial","volume":"75","author":"Sedighiyan","year":"2021","journal-title":"Int J Clin Pract"},{"key":"10.3233\/JAD-240212_ref437","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.neuint.2017.03.014","article-title":"The effects of omega-3 fatty acids and vitamin E co-supplementation on clinical and metabolic status in patients with Parkinson\u2019s disease: A randomized, double-blind, placebo-controlled trial","volume":"108","author":"Taghizadeh","year":"2017","journal-title":"Neurochem Int"},{"key":"10.3233\/JAD-240212_ref438","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/npp.2017.160","article-title":"Omega-3 polyunsaturated fatty acids in youths with attention deficit hyperactivity disorder: A systematic review and meta-analysis of clinical trials and biological studies","volume":"43","author":"Chang","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.3233\/JAD-240212_ref439","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10555-015-9572-2","article-title":"Omega-3 polyunsaturated fatty acids and cancer: Lessons learned from clinical trials","volume":"34","author":"Nabavi","year":"2015","journal-title":"Cancer Metastasis Rev"},{"key":"10.3233\/JAD-240212_ref440","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1177\/0269881120981392","article-title":"Effects of omega-3 polyunsaturated fatty acids supplements on psychopathology and metabolic parameters in schizophrenia: A meta-analysis of randomized controlled trials","volume":"35","author":"Goh","year":"2921","journal-title":"J Psychopharmacol"},{"key":"10.3233\/JAD-240212_ref441","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2478\/jbcr-2022-0013","article-title":"Role of diet and supplementation with omega-3 polyunsaturated fatty acids for managing chronic fatigue in patients with relapsing-remitting multiple sclerosis","volume":"15","author":"Ovcharova","year":"2022","journal-title":"J Biomed Clin Res"},{"key":"10.3233\/JAD-240212_ref442","doi-asserted-by":"crossref","first-page":"e0162368","DOI":"10.1371\/journal.pone.0162368","article-title":"Effectiveness of omega-3 polyunsaturated fatty acids in non-alcoholic fatty liver disease: A meta-analysis of randomized controlled trials","volume":"11","author":"He","year":"2016","journal-title":"PLoS One"},{"key":"10.3233\/JAD-240212_ref443","first-page":"CD005139","article-title":"Anti-vascular endothelial growth factor for neovascular age-related macular degeneration","volume":"8","author":"Solomon","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-240212_ref444","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.ophtha.2023.02.001","article-title":"A randomized controlled trial of OPT-302, a VEGF-C\/D inhibitor for neovascular age-related macular degeneration","volume":"130","author":"Jackson","year":"2023","journal-title":"Ophthalmology"},{"key":"10.3233\/JAD-240212_ref445","doi-asserted-by":"crossref","first-page":"684638","DOI":"10.3389\/fphar.2021.684638","article-title":"Direct oral anticoagulants: From randomized clinical trials to real-world clinical practice","volume":"12","author":"Roberti","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.3233\/JAD-240212_ref446","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s40119-015-0054-y","article-title":"Current clinical trials on the use of direct oral anticoagulants in the pediatric population","volume":"5","author":"von Vajna","year":"2016","journal-title":"Cardiol Ther"},{"key":"10.3233\/JAD-240212_ref447","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3390\/jmse9111173","article-title":"Applications of chitin in medical, environmental, and agricultural industries","volume":"9","author":"Dave","year":"2021","journal-title":"J Mar Sci Eng"},{"key":"10.3233\/JAD-240212_ref448","doi-asserted-by":"crossref","first-page":"460","DOI":"10.3390\/md20070460","article-title":"Chitin and chitosan: Prospective biomedical applications in drug delivery, cancer treatment, and wound healing","volume":"20","author":"Baharlouei","year":"2022","journal-title":"Marine Drugs"},{"key":"10.3233\/JAD-240212_ref449","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/psyg.12021","article-title":"Cilostazol improves cognitive function in patients with mild cognitive impairment: A retrospective analysis","volume":"13","author":"Taguchi","year":"2013","journal-title":"Psychogeriatrics"},{"key":"10.3233\/JAD-240212_ref450","doi-asserted-by":"crossref","first-page":"e89516","DOI":"10.1371\/journal.pone.0089516","article-title":"Cilostazol add-on therapy in patients with mild dementia receiving donepezil: A retrospective study","volume":"9","author":"Ihara","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-240212_ref451","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.ahj.2007.12.024","article-title":"Systematic review and meta-analysis of randomized clinical trials appraising the impact of cilostazol after percutaneous coronary intervention","volume":"155","author":"Biondi-Zoccai","year":"2008","journal-title":"Am Heart J"},{"key":"10.3233\/JAD-240212_ref452","first-page":"CD003748","article-title":"Cilostazol for peripheral arterial disease","volume":"1","author":"Robless","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.3233\/JAD-240212_ref453","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/clc.4960250303","article-title":"Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication","volume":"25","author":"Smith","year":"2002","journal-title":"Clin Cardiol"},{"key":"10.3233\/JAD-240212_ref454","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1212\/01.wnl.0000335163.88054.e7","article-title":"Growth hormone secretagogue MK-677: No clinical effect on AD progression in a randomized trial","volume":"71","author":"Sevigny","year":"2008","journal-title":"Neurology"},{"key":"10.3233\/JAD-240212_ref455","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1093\/nutrit\/nuw029","article-title":"Use of ghrelin in cachexia syndrome: A systematic review of clinical trials","volume":"74","author":"Mansson","year":"2016","journal-title":"Nutr Rev"},{"key":"10.3233\/JAD-240212_ref456","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/B978-0-12-381272-8.00026-X","article-title":"Clinical trial of ghrelin synthesis administration for upper GI surgery","volume":"514","author":"Takiguchi","year":"2012","journal-title":"Methods Enzymol"},{"key":"10.3233\/JAD-240212_ref457","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1021\/acs.jmedchem.1c02191","article-title":"Advances in the development of nonpeptide small molecules targeting ghrelin receptor","volume":"65","author":"Giorgioni","year":"2022","journal-title":"J Med Chem"},{"key":"10.3233\/JAD-240212_ref458","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s12937-016-0214-5","article-title":"Two ghrelin receptor agonists for adults with malnutrition: A systematic review and meta-analysis","volume":"15","author":"Su","year":"2016","journal-title":"Nutr J"},{"key":"10.3233\/JAD-240212_ref459","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/acn3.761","article-title":"Immunotherapy with ponezumab for probable cerebral amyloid angiopathy","volume":"6","author":"Leurent","year":"2019","journal-title":"Ann Clin Transl Neurol"},{"key":"10.3233\/JAD-240212_ref460","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12883-017-0800-y","article-title":"Cilostazol as an add-on therapy for patients with Alzheimer\u2019s disease in Taiwan: A case control study","volume":"17","author":"Tai","year":"2017","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-240212_ref461","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/JGP.0b013e31819431ea","article-title":"A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: Pilot follow-up study","volume":"17","author":"Arai","year":"2009","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-240212_ref462","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/j.1447-0594.2012.00866.x","article-title":"Effects of cilostazol on cognition and regional cerebral blood flow in patients with Alzheimer\u2019s disease and cerebrovascular disease: A pilot study","volume":"13","author":"Sakurai","year":"2013","journal-title":"Geriatr Gerontol Int"},{"key":"10.3233\/JAD-240212_ref463","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s13311-018-00708-x","article-title":"Efficacy of cilostazol administration in Alzheimer\u2019s disease patients with white matter lesions: A positron-emission tomography study","volume":"16","author":"Lee","year":"2019","journal-title":"Neurotherapeutics"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-240212","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T09:58:31Z","timestamp":1777370311000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-240212"}},"subtitle":[],"editor":[{"given":"Masafumi","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2024,7,16]]},"references-count":461,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-240212","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,16]]}}}